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Abstract 
 
 
 
Introduction:  Neck pain is common and is a significant medical and socioeconomic 
problem in New Zealand.  There are many treatments for neck pain, however the 
effectiveness of manual treatment for neck pain is poorly established.  The aim of the 
present study is to document the effectiveness of an emergent manual therapeutic 
technique Simple Contact in five subjects suffering from chronic neck pain. 
 
Methods:  A prospective single-system research design using an A-B-C protocol was 
used to evaluate the effectiveness of the intervention Simple Contact in reducing 
levels of pain intensity, disability due to neck pain and fear avoidance behaviour, and 
increasing functional status levels.  Subjects satisfying the study inclusion and 
exclusion criteria commenced a 9-10 week study consisting of a 3-4 week baseline 
period followed by a 3 week intervention period and a 3 week follow-up period.  
Outcome measures used to record levels were Quadruple Visual Analogue Scale, 
Neck Disability Index, Tampa Scale for Kinesiophobia, Fear Avoidance Beliefs 
Questionnaire and Patient Specific Functional Scale. 
 
Results:  Visual analysis of the data was used to attempt to identify any change in 
outcome measures that might be due to the intervention.  Where relevant, trendlines 
were fitted to data from all three phases and to data from the intervention and follow-
up phases.  Variability of data and limited data points in the baseline phase make it 
difficult to conclude whether or not the intervention had an effect.  Electronic 
submission of results by subjects allowed subject compliance to be checked.  Poor 
compliance with scheduled dates for submission of data seriously weakens the 
integrity of the study and the ability to confidently draw conclusions from the results.  
This identifies a methodological weakness for studies reliant on self-report measures 
of change. 
 
Conclusions:  The current research was not able to make conclusions as to the 
effectiveness of the intervention Simple Contact on reducing levels of chronic neck 
pain in the five subjects studied.  However, visual analyses of the results suggest that 
 v 
the intervention was having no detectable effect on the outcomes measured.  Future 
research in this area should attempt to obtain more baseline data and maximise 
compliance with scheduled dates of submission of data by subjects. 
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Glossary 
 
Chronic Pain:  “Pain that persists for extended periods of time (i.e., months or years), 
that accompanies a disease process (e.g., rheumatoid arthritis), or that is associated 
with an injury that has not resolved within an expected period of time” (Turk & 
Melzack, 2001 pp. 4) 
 
Dysfunction:  “Impaired or altered function of related components of the somatic 
system: skeletal, arthroidal and myofascial structures, and related vascular, lymphatic 
and neural elements.” (Jones, 2003 pp. 157) 
 
 
Hypervigilance:  Abnormally increased arousal, responsiveness to stimuli, and 
scanning of the environment for threats (Dorland & Newman, 2003) 
 
Minimum Clinically Important Difference (MCID): The minimum level of change 
recorded in an outcome measure that is considered to be clinically relevant. 
 
Nociceptor:  “A receptor preferentially receptive to a noxious stimulus or a stimulus 
which would become noxious if prolonged” (Merskey & Bogduk, 1994. pp 213) 
 
Pain:  “An unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage” (Merskey & Bogduk, 
1994. pp 210) 
 
Serial Dependency:  Correlation existing between sequential measures from the same 
individual (Ottenbacher & Hinderer, 2001) 
 
Simple Contact:  The manual therapeutic technique designed to facilitate an 
environment ideomotor movements may freely occur (Dorko, n.d.-b) 
 
Single System Design (SSD) also called Single System Research Design (SSRD):  
Quasi-experimental, prospective research design, using a sample of one (n = 1).  The 
design involves sequential introduction and withdrawal of an intervention.  The effect 
of the intervention may then be assessed through one or more outcome measures 
through repeated measurements (Sim, 1994). 
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Chapter 1:Literature Review 
 7 
Introduction 
 
Despite the prevalence of research regarding incidence and epidemiology of neck 
pain, little literature exists regarding the effectiveness or efficacy of manual therapy in 
the treatment of neck pain (Carroll et al., 2008).  Chronic neck pain, as with other 
chronic conditions, is generally considered to be associated with a multifactorial 
aetiology and does not lend itself to simple diagnosis.  In clinical terms, there are 
often difficulties in pinpointing an anatomical structure that may be the source of 
nociception underlying the pain symptoms (Apkarian, Bailiki, & Geha, 2009).  
Several theoretical models exist that attempt to explain the mechanisms of neck pain, 
including biomechanical, neurological and cognitive behavioural models.  An 
emergent therapeutic technique may offer a way of reconciling such a complex 
aetiological picture.  With foundations in psychological and physiological literature 
regarding instinctual motor behaviour, termed ideomotion, this manual therapeutic 
technique Simple Contact pioneered by Barrett Dorko in the early 2000s may be a 
viable and effective method for the treatment of chronic neck pain. 
 
The research investigation reported in this dissertation employed a single system 
design to investigate whether ideomotor-based therapy was effective in the treatment 
of chronic neck pain.  Five subjects with neck pain of a minimum 6-months duration 
were enrolled in the study, and monitored over a 9-week period.  During this 9-week 
period, validated outcome measures for disability, pain levels, fear avoidance factors 
and functional status were employed to measure change.   
 
The dissertation begins with a review of basic pain physiology before exploring some 
of the theories regarding the development and maintenance of chronic pain.  It then 
provides a context for and outline of ideomotor behaviour, before presenting a series 
of single system (n=1) investigations.  Vignettes describing the patients and their 
relevant health information will be presented, followed by results and discussion 
regarding the patients involved in the study.  Finally a section of general discussion is 
presented including a discussion of the methods employed and consideration of 
important weaknesses of the study and research design in general.  
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Background 
 
Pain review 
 
Nociception1 generated outside the central nervous system (in the periphery) is 
generally of three types: i) nociceptive afferent signals due to mechanical deformation 
of tissues; ii) generated by chemical irritation of tissues by inflammatory mediators 
(see footnote 1), such as muscle or bone; or iii) thermal nociception; this being less 
relevant in considering musculoskeletal pain mechanisms (Hill 2001; Julius and 
Basbaum 2001; Charlton 2005).  Certain characteristics of these different types of 
nociception exist that may facilitate their identification by clinicians and may be 
apparent during medical interviews.  ‘Mechanical pain’, generated by deformation of 
innervated tissues, (e.g., Hill 2001; Julius and Basbaum 2001; Charlton 2005) may be 
aggravated with certain movements, relieved by certain movements or positions and 
can be intermittent.  ‘Chemical pain’2 may be contrasted with mechanical pain in that 
‘chemical pain’ is relatively constant in intensity, possibly worse after periods of 
inactivity, and is not relieved a great deal through positional change (Magee, 2006).  
Movement may help to relieve chemical pain through cycling of interstitial and 
lymphatic fluid in tissues, thereby facilitating removal of inflammatory chemicals.  
Indeed resolution of chemical pain other than through the use of anti-inflammatory 
medication requires blood circulation to ameliorate nerve tissue irritation (Hill 2001; 
Julius and Basbaum 2001; Charlton 2005). 
 
Some pain theorists (e.g., Melzack, 2001; Moseley, 2003) contend that there is a link 
between pain and movement in that both stem from a common multi-system process; 
pain perception and localisation of pain occur concurrently with the generation of 
impulses leading to motor action serving to resolve the perceived threat.  Wall (1999) 
                                                
1 Nociception is a stimulus arising from a Nociceptor, defined as “A receptor preferentially receptive to 
a noxious stimulus or a stimulus which would become noxious if prolonged” (Merskey & Bogduk, 
1994. pp 213).  This definition should be contrasted to the definition of pain, which is “An unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or described in 
terms of such damage” (Merskey & Bogduk, 1994. pp 210) 
2 Predominantly associated with chemical nociception of inflammatory mediators. Often termed 
‘inflammatory soup’ inflammatory mediators include bradykinin, histamine, seratonin, nitric oxide 
(NO), nerve growth factor (NGF) K+, H+ and the prostaglandins. Collectively these mediators serve to 
sensitise normally high-threshold nociceptors so that they respond to normally innocuous stimulation 
(Chapman, Tuckett, & Song, 2008). 
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suggested that pain may be resolved through a specific motor process, and that this 
appropriate response would manifest in an instinctual motor pattern.  Using 
movement, such as passive movement of joints (eg mobilisation/articulation) or soft-
tissues (eg massage techniques) and exercise prescription to reduce pain levels and to 
improve function, is not a new concept to manual therapists.  Historically, the way 
manual therapists treat musculoskeletal dysfunction can be expressed simplistically; 
they either move – massage, articulation or manipulation – or stretch their patient’s 
tissues or offer advice regarding useful movements or positions patients can employ 
themselves in order to treat pain or dysfunction (Long, Donelson, & Fung, 2004; 
Silvernail, 2006).  When a therapist prescribes a ‘correct movement’ for a 
musculoskeletal problem, there is the potential for unexpected outcomes; the patient 
may not respond to the movement associated with the diagnosis, or may respond to a 
movement unrelated to treatment of the tissue causing symptoms (Long, Donelson, & 
Fung, 2004).  Authors have questioned the utility of prescribing tissue-specific 
exercise programmes; even given a non-specific exercise program it is common for 
patients to have reduced pain (Long, Donelson, & Fung, 2004).  Returning to the 
premise of Wall (1999) that pain may be relieved using specific instinctual motor 
patterns generated in response to perception of pain, then the need for a practitioner to 
identify or prescribe the correct movement patterns becomes redundant; the capacity 
must be present within the patient to express the correct/corrective movement, and as 
such the difficulty for the practitioner becomes learning how to encourage the 
expression of this movement (Dorko, 2003). 
 
Chronic Pain 
 
Chronic pain may be defined as “Pain that persists for extended periods of time (i.e., 
months or years), that accompanies a disease process (e.g., rheumatoid arthritis), or 
that is associated with an injury that has not resolved within an expected period of 
time” (Turk & Melzack, 2001 pp. 4).  Precisely when the healing phase comes to an 
end is problematic to define, and as such clinical practice tends to use standard time 
periods as markers, with chronic pain being defined as pain that persists at the 6 
month point after the initial occurrence (Apkarian, Bailiki, & Geha, 2009).  Such time 
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frames, however, tend to be arbitrary markers and may not directly represent the 
actual underlying mechanisms of pain development (Apkarian, Baliki & Geha, 2009). 
 
Somatic manifestations of chronic pain are seldom simple, with often several tissues 
being observed to contribute to the overall clinical picture (Apkarian, Baliki & Geha, 
2009).  Apkarian et al., (2009) use the example of chronic low back pain as an 
example of a notoriously complex clinical picture, with relative involvement of 
tissues such as nerve and muscle tissue or processes such as joint degeneration having 
varying amounts of contribution to the overall dysfunctional pattern.  In cases of 
chronic low back pain it is generally difficult to ascertain which tissue is injured or 
dysfunctional (Apkarian, Baliki & Geha, 2009).  Similarly, in cases of chronic neck 
pain there is little evidence of specific pathology in the majority of cases, with 
nociception potentially originating from the cervical analogues of tissues and 
structures described for low back pain (Bogduk & Barnsley, 2000).  Neck pain is 
therefore commonly labelled as pain of unknown origin or non-specific neck pain 
(Bogduk & Barnsley, 2000). 
 
There are many models for the development of chronic pain, with some authors 
implicating anatomical (e.g., Pye et al., 2004), biomechanical (e.g., Okuda et al., 
2004), or genetic (e.g., MacGregor, Andrew, Sambrook, & Spector, 2004; Sambrook, 
MacGregor, & Spector, 1999) factors predicting the occurrence of chronic pain.  
Neural models influencing the development of chronic pain are also well explored.  
For example, Hagelberg et al., (2004) examined the role of dopamine in the CNS in 
cases of chronic pain, suggesting that the degree to which dopamine is bound to D2 
receptors in the basal ganglia could be used as a marker for diagnosis of chronic pain.  
Another study of neural theories of pain conducted by Apkarian et al., (2009) 
proposes a model of neurological reorganisation, in which the transition from acute to 
chronic pain is characterised by a reorganisation of neural pathways, the medial and 
lateral spinothalamic tracts, over time.  The conclusion of this model is that the shift 
from acute to chronic pain is accompanied with a shift in perception of pain, with the 
perception of pain becoming a sign of an internalised disease state as opposed to a 
sign of external threat. 
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Cognitive behavioural theories relating to the development of chronic pain are also 
salient when considering a multifactorial model.  One such theory is that of fear 
avoidance behaviour as a factor in the development of persistent disability.  This 
cognitive behavioural model stresses the role of catastrophisation of the pain 
experience, leading to subsequent hypervigilance3 (Boersma et al., 2004).  Added to 
this fear is avoidance of activity perceived to be associated with pain, fuelled by the 
idea that such activity will exacerbate the pain or will cause injury (Vlaeyen & 
Linton, 2000).  This theory has support from research.  Back pain studies have shown 
that due to fear of re-injury, patients over-predict the pain a back-stressing movement 
will produce and that when exposed to these movements patients corrected their 
expectations of pain and harm (Crombez, Vervaet, Lysens, Eelen, & Baeyens, 1996; 
Goubert, Francken, Crombez, Vansteenwegen, & Lysens, 2002).  Research also 
shows that there is a strong association between disability and pain-related fear in 
patients with chronic pain (Crombez, Vlaeyen, Heuts, & Lysens, 1999; Vlaeyen, 
Kole-Snijders, Boeren, & H, 1995; Vlaeyen, Kole-Snijders, Rotteveel, Ruesink, & 
Heuts, 1995) and interestingly that pain-related fear is a predictor of future disability 
(Fritz & George, 2002; Klenerman et al., 1995).  The implications of such research 
are that fear-avoidance behaviour is likely to play an important role in not only 
maintenance of chronic pain but also its development.  Further, treatment which takes 
into account not only anatomical aspects of pain but also psychosocial aspects may be 
beneficial to many sufferers of chronic pain. 
 
 
Instinctual ‘Ideomotor’ Movement 
 
The existence of non-conscious movement patterns has been relatively well identified 
within psychology and physiology (Hyman, 1999).  An early description of instinctual 
motor patterns was made by Carpenter and reprinted in The Proceedings of the Royal 
Institution (Carpenter, 1852). Carpenter identified three categories of instinctual or 
non-conscious motor behaviour: excitomotor (e.g., swallowing or breathing); 
sensorimotor (e.g., blinking); and the third, and relevant to the current review, 
                                                
3 Hypervigilance can be defined as “abnormally increased arousal, responsiveness to stimuli, and 
scanning of the environment for threats” (Dorland & Newman, 2003) 
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ideomotor behaviour, the non-conscious motor patterns.  Subsequent experiments into 
ideomotor behaviour have been summarised by Spitz (1997).  The studies Spitz 
describes demonstrate an apparent muscle movement based on a non-conscious desire 
toward an apparent movement state.  Examples of this include the subject being asked 
to imagine falling and manifesting movements designed to catch their balance such as 
swaying, or when asked to imagine lifting an object, subjects showed contraction of 
muscles in the arm associated with that lifting movement (Spitz, 1997).  It should be 
noted that while ideomotor movements tend to be slow, larger range movements of 
the trunk and neck- at least within a therapeutic context- ideomotor behaviour may 
not always be easily visible (Rickards & Lucas, 2009), given the complex interaction 
of functional units needed to initiate movement. 
 
Further examples of ideomotor behaviour are the involuntary moments that make up 
non-verbal communication, such as facial expression or body posture (popularly 
labelled as ‘body language’) (Spitz, 1997), yawning or postural correction when 
seeking to avoid discomfort – such as moving weight-bearing from foot to foot or 
shifting in a chair (Lehmann, 1979).  McCarthy, Rickards & Lucas (2007) suggest this 
last example is descriptive of ideomotor activity as being a part of homeostatic or 
corrective functions.  Interestingly, a good deal of the literature relating to ideomotor 
activity are found within the realms of illusory experiences (McCarthy, Rickards, & 
Lucas, 2007) such as dowsing, the ouija board, or pendulum diagnosis where 
ideomotion has been used as the scientific rationale for the events observed (Klinger 
1971; Spitz 1997; Hyman 1999; Hall 2003).  Further, ideomotion has been nominated 
as one of the potential mechanisms of action for therapeutic techniques such as energy 
work (Hall, 2003; Hyman, 1999) and may provide an explanation for the palpatory 
phenomenon described in osteopathy in the cranial field (OCF) or craniosacral 
therapy (Hartman & Norton, 2002). 
 
Subsequently, the role of ideomotor activity may best be defined as the motor 
movements necessary to resolve the cognitive non-conscious need to reach a state of 
comfort (Rosenbaum, Meulenbroek, & Vaughan, 2001; Rosenbaum, van Heugten, & 
Caldwell, 1996; Short & Cauraurgh, 1997), a feed-forward and feed back mechanism 
(Kunde, Elsner, & Keisel, 2007).  Given the discussion presented above, it is not 
difficult to conceive of a situation in which awareness or imagining the desired end 
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state, such as the resolution of pain (Moseley, 2003; Wall & Melzack, 1999) could 
generate ideomotor behaviour which includes the correct or corrective movement 
needed to reach a state of comfort (Spitz, 1997) - the pain free state. 
 
Ideomotor Movement as Therapy 
 
As a therapeutic tool, ideomotion is a relatively new development based upon a 
foundation of psychological/physiological research and theory.  Barrett Dorko (2003), 
building on this background literature of ideomotion, hypothesised that reduction in 
pain symptoms could be achieved by removing inhibition/suppression of instinctual 
motor patterns and encouraging these ideomotor patterns to emerge (Dorko, 2003, 
n.d.-b).  Simple Contact is the name used by Dorko to describe the manual therapeutic 
technique designed to facilitate an environment where ideomotor movements may 
freely occur (Dorko, n.d.-b).  As a form of therapy, Simple Contact attempts to utilise 
the ideomotor theory.  Its application by the practitioner is intended to encourage and 
facilitate the emergence of the instinctual motor patterns required to resolve simple 
mechanical pain (Dorko, 2003).  This is based upon the premise offered by 
foundational theorists such as James (1890) suggesting that ideomotion is expressed 
maximally unless a concurrent antagonistic impulse exists in the mind.  Dorko (2003) 
proposed that such expression of movements may well have become culturally or 
socially unacceptable.  They are limited by what one may reasonably expect to be 
permitted to do in a given social situation and thereby inhibited.  Thus demands 
required of the social environment may generate simultaneous antagonistic 
representation.  Interestingly, Dorko (n.d-b) also suggests that such concurrent 
inhibition of the ideomotor impulse may manifest as isometric muscle contraction.  
Where traditional manual therapeutic approaches aim to relax this contracted tissue 
through the use of stretching, exercise or manipulation (McCarthy, Rickards, & 
Lucas, 2007), Dorko (n.d-b). proposes that encouragement of the expression of 
instinctual motor behaviour resulting in isotonic contraction may be more appropriate. 
 
Given the potential for ideomotor behaviour to have been repressed through a process 
of growing awareness of social norms, Dorko (2003) suggests that the role of the 
practitioner becomes one of providing the appropriate environment necessary for 
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ideomotion to occur.  Simple Contact employs many of the same handholds as may be 
utilised in other indirect techniques described in contemporary texts of manual 
technique such as Ward (2006).  The technique employs light touch to facilitate the 
expression of ideomotor patterns together with verbal communication (Dorko, n.d.-a).  
This is similar to the approach used by psychotherapists while employing Authentic 
Movement, an encouraged expression of ideomotion designed to explore 
psychological pain through generating an understanding of the link between the 
psyche and soma (Wyman-McGinty 1998; Steckler 2006). 
 15 
Epidemiology, prognosis and treatment of neck pain 
 
Whilst no published literature exists for the epidemiology of neck pain in New 
Zealand, data obtained from the Accident Compensation Corporation (ACC) of New 
Zealand suggests that from July 2003 until July 2007 there were 12,723 new claims 
for pain relating to neck injuries, with ongoing (chronic) claims increasing over the 
period of five years from 4,198 in 2003 to 4,941 in 2007 (Accident Compensation 
Corporation, 2008).  Of these claimants, the gender ratio was approximately equal, 
and most claims were made by people within an age range of 19-60 years of age 
(Accident Compensation Corporation, 2008).  Costs Incurred by ACC for neck injury 
claims for the four year time period described was up to $533,210.   
 
Outside of New Zealand, there is data to indicate that up to two thirds of people will 
suffer from neck pain in their lifetimes (Cote, Cassidy, & Carroll, 2003), and in the 
United States, neck pain is the second most common reason manipulative therapy is 
sought after low back pain (Clark & Haldeman, 1993).  Perhaps the best source of 
data regarding neck pain comes from a recent study commissioned by the United 
Nations and World Health Organisation.  The Bone and Joint Decade 2000-2010 Task 
Force on Neck Pain and its Associated Disorders (2008) conducted an exhaustive 
study into epidemiology, course4, and prognostic factors for neck pain within the 
general population.  They found that the 12-month prevalence of neck pain ranged 
from 12.1% to 71.5% in the general population, and from 27.1% to 47.8% in workers, 
and between 50% and 85% of those who experience neck pain at an initial point 
reporting neck pain again 1 to 5 years later (Carroll et al., 2008).  Findings regarding 
prognosis clearly indicated the multifactorial nature of chronic neck pain.  Younger 
age was associated with a better prognosis, while prior neck pain and poorer general 
health were associated with a worse prognosis (Carroll et al., 2008).  Interestingly, 
Carroll et al., (2008) also found that there was an association between becoming 
angry and frustrated and worrying, poorer psychological health and a poorer 
                                                
4 The term “course” was used by the review in preference to the term “natural history” which is 
generally understood to mean the course of the disease in the absence of intervention, and the authors 
state that it was unclear in many of the articles reviewed whether intervention took place.  
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prognosis.  A better prognosis was associated with a self-assured coping style and 
greater optimism and less need for socialisation (Carroll et al., 2008).   
Carroll et al., (2008) included in their systematic review an analysis of the benefits of 
different modalities of non-surgical treatments.  Mobilisation, manual therapy, 
educational videos appeared to be more effective than what they described as usual 
care and alternative or sham treatments for neck pain, however, no single modality 
appeared any more effective than any other (Carroll et al., 2008).  They conclude that 
more research into modifiable risk factors and new and innovative treatment for neck 
pain is clearly required (Carroll et al., 2008). 
 
Single System Design 
 
Within clinical research a general hierarchy of levels of evidence in relation to 
research designs exists. (Evans, 2003)  Topmost in that hierarchy are systematic 
reviews of literature, followed by randomised controlled trials.  These two designs are 
considered to be the most powerful of clinical research designs.  Lower on the list are 
observational studies, useful for example when an historical case exists to be studied.  
The single system research design (SSRD), whilst not appearing on any of the 
standard hierarchies, would appear still lower on the design hierarchy.  Due to its 
prospective nature the SSRD would likely place above the case study, but lacking 
controls such as case control, would appear below observational studies.  Given the 
emergent nature of manual therapy utilising ideomotion, there is still much ground to 
be covered in order to investigate effectiveness.  The SSRD, providing a quasi-
experimental method to investigate the effectiveness of an intervention upon an 
individual, is often a useful design to achieve this end (Moran, 2005).  While 
relatively weak in comparison to an explanatory randomised controlled trial (RCT) in 
which patients are selected for homogeneity and variables are controlled in such a 
way as to make results generalisable to a larger population, the SSRD is still weakly 
capable of controlling for some extraneous variables such as co-intervention.  Whilst 
any results gained from an SSRD may not be generalised nor are predictive, they will 
at least objectively document outcomes of the single patient studied (Domholdt, 2005; 
Moran, 2005; Sanders, 2003) and may be capable of providing enough evidence to 
justify undertaking more powerful studies later. 
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Quasi-experimental research designs such as the SSRD are utilised to investigate 
effectiveness of a clinical treatment in a ‘real-life’ or pragmatic setting, and may be 
conducted in a clinical setting with small numbers of ‘real’ patients.  Single system 
design experiments allow customisation of treatment frequency, content and duration, 
such that any harm to subjects from events such as sub-optimal or inappropriate 
treatment is minimised (Sim, 1994).  In comparison, the design of explanatory 
randomised controlled trials requires selection of patients based on homogeneity and 
feature treatment interventions which have been predetermined and are standardised 
for all subjects, such that there is increased likelihood of suboptimal treatment due to 
the lack of intervention being targeted to specific individual case (Sim, 1994).  
Further, randomised controlled trials make assumptions based on aggregate data 
which may not be representative of any individual subject examined in the 
experiment, whilst an SSRD is able to offer predictions of possible responses based 
upon a set of observed clinical features presented by the individual (Rogan, Hickman, 
Harris, & Heriza, 2008). 
 
There are several important limitations of SSRDs.  The major limitation is the weak 
control they provide over extraneous variables.  Internal validity may be threatened 
where extraneous variables may influence the dependent variable.  An SSRD cannot 
account for the placebo effect due to its lack of control group, such that the 
appearance of recovery in a subject may be due to their belief in the effectiveness of 
the intervention rather than the actual effectiveness of the intervention itself.  
Limitations also exist in the analysis of data, which is typically simplistic involving 
graphical representation only (Bithell, 1994).  Assumptions, such as independence of 
data, are required to be able to employ inferential statistics.  Such independence of 
data cannot be fulfilled in the SSRD.  Serial dependence- where data points are 
strongly related- due to frequent recording for example may exist (Bithell, 1994).  
Treatment effects of one intervention session may be overstated, while subsequent 
treatment may have less apparent impact and thus be marginalised as less effective 
(Bithell, 1994). Benefits and limitations of the SSRD are summarised below in Table 
1. 
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Table 1: Benefits and limitations of the SSRD (After Fletcher, 2006; Sim, 1994) 
Benefits of SSRD Limitations of SSRD 
Conducted in a clinical setting History, maturation and frequent measures are 
known to alter the behaviour of the subjects, 
thus may have weak internal validity 
Weak external validity Do not require large numbers of participants 
Results may not be statistically analysed 
Treatment customised to individual patient 
minimising harm 
Lack of scientific credibility 
No control group, therefore no need to 
withhold treatment 
Hard to determine stable baseline 
Can be used for rare conditions Simplistic graphical representation 
Through use of replication and meta-analysis, 
some evidence as to a group reponse can be 
obtained 
Poor control over extraneous variables such as 
the placebo effect 
 
 
Previous Research 
 
Published research into the use of ideomotor-based therapy as a clinical therapeutic 
tool is limited.  One SSRD by McCarthy, Rickards & Lucas (2007) exists 
investigating the effectiveness of ideomotor therapy- Simple Contact- in a patient with 
chronic neck and shoulder-girdle pain.  Their findings were of a decrease in pain 
intensity and perceived disability concurrent with the introduction of ideomotor-based 
therapy, which they attributed as being due to the intervention (McCarthy, Rickards, 
& Lucas, 2007).  The authors also discussed the fact that providing basic education of 
pain neurophysiology may have influenced the outcome (McCarthy, Rickards, & 
Lucas, 2007).  At the time of writing the current work, one other unpublished SSRD 
series exists investigating the use of ideomotion as a therapeutic tool to address 
chronic pain (Rickards & Lucas, 2009).  In their research, Rickards & Lucas (2009) 
examine 4 patients with chronic neck and low back pain.  Their results were 
consistent with the findings of  McCarthy, Rickards & Lucas (2007), with 3 of 4 of 
the subjects studied recording clinically important decreases in disability, negative 
affect and pain intensity scores (Rickards & Lucas, 2009).   
 
Given the findings of the two studies described above the present study is clearly 
warranted, particularly given only two previous studies exist, and these are conducted 
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by the same research group.  With the cost associated with the case of chronic pain 
patients and the lack of clinical evidence of effectiveness of manual treatment 
previously discussed, new methods of treatment with proven effectiveness are needed.  
It is apparent that the occurrence of ideomotor behaviour employed in a clinical 
setting using Simple Contact requires evaluation. 
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Chapter 2: Methods 
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Research Aims 
 
To investigate the effect of ideomotor movements in patients chronic neck pain 
through the use of Simple Contact. 
 
Research Objectives 
 
To explore the potential for the reduction of pain symptoms and increase of function 
and quality of life. 
 
Research Design 
 
A prospective A-B-C SSRD was used to investigate the effectiveness of ideomotion 
in the treatment of patients with chronic neck pain.  Each individual study was of nine 
(in one case 10) weeks duration with each phase being of three weeks duration and 
following the preceded phase without intermission.  Phase A consisted of a three 
week baseline period in which multiple measures were collected, including quadruple 
visual analogue scale (QVAS), neck disability index (NDI), patient specific functional 
scale (PSFS), Tampa scale for kinesiophobia (TSK) and fear-avoidance beliefs 
questionnaire (FABQ).  These measures are further described below in the ‘outcome 
measures’ section.  No active treatment was employed during the baseline phase.   
 
Phase B was an intervention phase of three weeks duration.  During this phase a total 
of three, thirty minute treatment sessions employing Simple Contact to facilitate 
ideomotor movement expression took place at weekly intervals.  Self management 
was also encouraged, and consisted of daily homework sessions of ideomotor 
movements.  Each homework session was recommended to be of at least twenty 
minutes duration.  During phase B measurements took place in the form of pain 
intensity (QVAS), neck disability (NDI), functional ability (PSFS), fear of movement 
causing (re)injury (TSK and FABQ) being recorded three times weekly.  In addition a 
Pain Right Now visual analogue scale was recorded before and after each treatment 
session.   
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Phase C was a period of three weeks of self-management, during which the daily 
homework sessions of ideomotor movements continued.  Measurements during phase 
C were recorded using the same instruments.  No treatment was provided in this last 
phase.   
 
 
Subjects 
 
Subjects were recruited after a leaflet drop within suburbs surrounding the Mount 
Albert campus of Unitec New Zealand.  
Inclusion Criteria 
 
Subjects were to be between the ages of 18 to 60 years, and reported experiencing 
neck pain for at least six months duration, and were available to participate over the 
nine weeks scheduled for the study. 
 
Exclusion Criteria 
 
Subjects were excluded if they reported neck pain attributable to diagnosed disc 
pathology or other spinal pathology such as cancer, fracture, infection, 
rheumatological disease or any other medical condition.  Neck pain due to ongoing 
tissue damage, inflammatory conditions or nerve-root involvement was also an 
exclusion criterion. 
 
Consent and Withdrawal Criteria 
 
Subjects were presented with an information sheet describing the study and the 
requirements for measurement and attendance, and were requested to refrain from any 
other form of treatment for their pain during the nine week trial.  Ethics approval was 
granted by the Unitec Research Ethics Committee (Approval number 2007-789).  
Satisfied that they were fully informed as to the process of the research, subjects were 
then presented with a consent form to sign.   
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Enrolled subjects had the right to withdraw without notice or giving any reason at any 
point during the trial, and could withdraw their data up until two weeks following the 
conclusion of the trial.  Subjects were also to be withdrawn should side effects 
develop during the course of the treatment, including worsening of symptoms or the 
manifestation of any of the exclusion criteria detailed above. 
 
Intervention 
 
Simple Contact was used to facilitate the expression of ideomotor movements in each 
subject. In using Simple Contact, the technician does not seek to choreograph or 
suggest any particular movement or movements sets, but rather serves to facilitate the 
patient’s awareness of the potential for their own spontaneous movement such that 
they are able to allow it to occur (Dorko, n.d).  Rickards and Lucas (2009) describe 
the application of simple contact as needing to be of sufficient pressure to be barely 
detectable by the subject.  As the subject begins to move the practitioner merely 
‘follows’ the movements with their own hands and body (Rickards & Lucas, 2009).  
Hand holds utilised in the current study included contact with the head in the regions 
of frontal and occipital bones.  Contact with subjects’ shoulders at the region of the 
acromio-clavicular joint was also used, and occasionally contact was made with the 
pelvis at the level of the iliac crests bilaterally. 
 
Typically, treatment with Simple Contact takes place with the subject positioned in 
standing, seated or supine.  While the subject is seated or standing there is a greater 
freedom of movement, such that larger amplitude movements of the neck or trunk 
may be observed (Rickards & Lucas, 2009).  When the subject is supine such large 
scale movements are restricted, however, smaller movements, while not necessarily 
visible, may be palpated by the practitioner (Rickards & Lucas, 2009).   
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Outcome Measures 
 
The tools used to measure outcomes of the study are described in Table 2. 
 
 
 
 
Table 2: Description of Outcome Measures 
 
Neck Disability Index (NDI) 
 
This instrument was used to measure the extent to 
which disability due to neck pain was experienced by 
each subject. This tool has established validity and 
reliability (Vernon & Mior, 1991) 
Quadruple Visual Analogue Scale 
(QVAS) 
Intensity of pain was measured using the quadruple 
visual analogue scale (Carlsson, 1983b) which 
provides information regarding pain experienced 
‘right now’, average pain, pain at its worst and at its 
best. The QVAS is widely used and has established 
reliability and validity (Carlsson, 1983a). 
 
Patient Specific Functional Scale 
(PSFS) 
The Patient Specific Functional Scale, as the name 
suggests, quantifies functional levels for the patient 
but uses activity limitation in normal daily activity as 
selected by the patient, and as such is specific to the 
individual being measured (Chatman et al., 1997).  
Changes in functional ability are plotted against the 
original measure of disability and progress or lack 
thereof may then be documented. The PSFS also has 
demonstrated validity and reliability (Chatman et al., 
1997). 
 
Tampa Scale for Kinesiophobia 
(TSK) and Fear-Avoidance 
Beliefs Questionnaire 
Recent interest with regard to chronic pain conditions 
and relevant to neck pain has been drawn to the 
potential that patients suffering with chronic pain 
may exhibit fear-avoidance behaviours; that is, they 
find themselves unable to perform movements due to 
fear that such movements may generate pain or 
symptoms (Vlaeyen & Linton, 2000).  To measure 
fear avoidance, two concurrent measures were: the 
tampa scale for kinesiophobia and the fear-avoidance 
beliefs questionnaire. Both of these measures have 
been tested for reliability and validity and found to be 
effective (Swinkels-Meewisse, Swinkels, Verbeek, 
Vlaeyen, & Oostendorp, 2004) 
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Subject Vignettes 
 
Subject 1 
 
Subject 1 was a 24 year old female part-time office administrator, enrolled in the 
study after fulfilling the inclusion criteria and giving informed written consent.   
She described the onset of her neck pain as occurring during a music concert when 
she was elbowed in the neck by an enthusiastic listener.  This occurred when she was 
16 years of age.  Subject 1’s pain initially improved at the time of first onset, but had 
subsequently worsened, and at the time of recruitment was unchanging or possibly 
worsening. The distribution of neck pain was bilateral shoulders, especially the left, 
and the “base of the neck” up into the “where the head joins5”.  Pain was aggravated 
by sustained sitting postures and bending forward and relieved by medication or 
sometimes breathing exercises or stretches.  Headache was a feature associated with 
her neck pain, with the subject in addition suffering from migraine severe enough to 
require hospitalisation on some occasions.  She described herself as being 
“dependent” on codeine-based medication such as Mercyndol® containing codeine, 
paracetamol and doxylamine succinate, or Panadeine®, taking these drugs daily. This 
was sometimes supplemented with Nurofen® Plus® or Panadol®.  In addition when 
suffering from migraine she self medicated with Imigran®, a sulphonamide drug 
based on sumatriptan and taken for migraine headache.  Her general practitioner had 
also prescribed her Citalopram®, a selective serotonin reuptake inhibitor (SSRI) for 
depression, Amitriptyline for pain control and migraine and Diazepam®, a 
benzodiazepine tranquiliser possibly prescribed for sleep or as a muscle relaxant. 
Sleep patterns were disturbed, and the subject reported using a moulding pillow and 
lying on her left side were the most comfortable way to sleep.  Previous treatment had 
included chiropractic, osteopathy and most recently acupuncture.  The subject 
displayed good sitting and standing posture, with minimally impaired cervical 
movements in protrusion, retraction flexion, extension, sidebending right and left and 
rotation right and left. 
 
 
 
                                                
5 See Appedix 8 for bodychart 
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Subject 2 
 
Subject 2 was a 40 year old female telemarketer, enrolled in the study after fulfilling 
the study inclusion criteria giving informed written consent. Twenty-one years ago 
subject 2 had been swimming at a surf beach and collided with a surfer, with the 
surfboard hitting her neck “high on the right”.  The subject reported that pain levels 
had remained unchanged since the accident.  The distribution of the pain was 
described by the subject as “the entire right side of the neck and behind the eyes6”, 
and was aggravated by sitting- her neck feeling “compressed” in this position- and 
relieved by hanging upside-down or by Nurofen®.  There was no headache associated 
with the neck complaint.  Medication used were Nortriptyline hydrochloride, a 
tricyclic antidepressant, and Inhibase Plus®, containing the angiotensin-converting 
enzyme inhibitor cilazapril, and hydrochlorothiazide for diuresis to control 
hypertension.  She also self medicated with 120ml of Noni juice for pain.  The subject 
described her sleep as being “disturbed”, often waking in the night, and she mainly 
sleeping on her right side and back and using one feather pillow.  Previous treatment 
for her neck pain included chiropractic, which provided relief at the time of treatment 
but had very short longevity, and energy work “off and on” since the onset of the 
pain.  Observation of the subject revealed a protruded head in both sitting and 
standing positions.  Cervical extension was moderately impaired, protrusion and 
retraction minimally impaired. Flexion was full and free from restriction. Rotation 
was moderately impaired both right and left, and sidebending was minimally impaired 
both right and left. 
 
                                                
6 See Appendix 9 for bodychart 
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Subject 3 
 
Subject 3 was a 29 year old mother of 3 who was due to return to her job as a 
helpdesk manager during the trial, after having been on maternity leave “for some 
months”.  She was recruited to the study after fulfilling the study inclusion criteria 
and giving informed written consent.  The initial onset of subject 3’s pain was during 
a period with her company 2 ½ years ago where her workload had been at an 
unprecedented high and she reported her pain levels had remained unchanging since 
this time.  The distribution of the pain was on “both sides” of her neck around the 
“bottom of the skull7” and often resulted in a headache which typically moved 
forward to be felt behind her eyes.  The neck pain was aggravated by “leaning her 
head backwards” or sitting for sustained periods, and was relieved by massage and 
heat.  Subject 3 did not take any medication for her pain, although she described 
recently ceasing to take paracetamol prescribed following a caesarean section during 
the birth of her youngest child.  There was a pattern of disturbed sleep and subject 3 
reported sleeping for only 2 hours per night.  She was unsure what factors caused such 
a disturbance, and suggested she was aware of her neck pain upon waking but did not 
think the pain was what was causing her to wake.  Previous treatment had been 
limited to the “occasional massage”.   The subject was not sure how frequently she 
received massages.  Examination revealed a protruded head posture in both sitting and 
standing positions.  There was significant cervical movement impairment in retraction 
and minimal movement impairment in protrusion and sidebend right and left. 
 
 
 
 
 
 
 
 
 
 
                                                
7 See Appendix 10 for bodychart 
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Subject 4 
 
A 25 year old female student of osteopathy, subject 4 was enrolled in the study after 
fulfilling the study inclusion criteria and giving informed written consent.  The 
subject began noticing some neck pain while working on highschool computers, but 
was unsure precisely when she first noticed this neck pain.  She had her first notable 
episode at 18 years of age while working as an office secretary- a job she continued 
with until 24 years of age.  Since this first episode she described her pain as 
worsening over time.  The areas effected by pain were the right side of her neck 
where it “joined her skull” and “at the base”, and the “left side” felt “tight8”.  She 
reported suffering from headache, and while this was not present during every episode 
of neck pain it did not arise independent of the neck pain.  The distribution of the 
headache was in the frontal region of the head, always unilateral and always on the 
right.  The neck pain was aggravated by cervical extension and relieved by warmth, 
and had been treated with chiropractic and osteopathic manipulation, which provided 
relief for 3-4 days.  She was unsure when she had received her first treatment and how 
frequently these treatments had occurred.  Subject 4 tended to sleep well, getting 
around 8 hours per night, unless she was engaged in extended computer work at 
which time sleeping hours decreased.  She used a medium sized pillow, and slept on 
her back.  Medication was limited to dietary supplements of iron and zinc.  Physical 
examination revealed a minimally protruded head during sitting and standing 
positions.  There was minimal impairment in cervical retraction, flexion, extension, 
sidebend left and rotation left, and moderate impairment in sidebend right. 
 
 
 
 
 
 
 
 
 
 
                                                
8 See Appendix 11 for bodychart 
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Subject 5 
 
Subject 5 was a 49 year old female computer operator, enrolled in the study after 
fulfilling the study inclusion criteria and giving informed written consent.  Her neck 
pain began during a long-haul flight from Ireland to New Zealand in 1999, and since 
that time has been worsening, particularly noticeable when seated working for long 
periods.  The hours spent working were erratic, and subject 5 was required to work for 
up to 12 hours per day for a changing roster of days.  These hours would vary from 
daytime to night-time and in number depending on the shift roster.  This intensive 
work schedule would be followed by extended periods with no work at all.  The 
distribution of the pain was described as “across both shoulders” and “up into the 
neck all the way to the head9”, aggravated by rotation both directions with right being 
worse than left, and relieved by analgesic medication.  Such medication was 
Panadol®, Nurofen® and Paramax®, containing paracetamol and metoclopramide 
hydrochloride.  The Paramax® was used to control headache which was usually right 
sided, beginning at the “back of the head” and moving anterolaterally into the 
temporal and retro-orbital regions.  This headache was often accompanied by nausea 
and vomiting, but no photophobia, phonophobia or visual disturbance was 
experienced.  Headaches did not coincide with neck pain.  Sleeping patterns 
experienced by the subject tended to be good, however could become disturbed 
during periods of work, where shifts necessitated either sleeping during the day or 
changeable working hours precipitating inconsistent daily patterns.  At these times 
sleep was often interrupted after about 2 hours, becoming fitful.  Subject 5 used a 
thick pillow, and found it most comfortable to sleep on her back.  Previous treatment 
included chiropractic, which the subject recalled “maybe helped a bit”.  The subject 
was unsure as to the frequency of previous treatment, and described it as 
“occasional”.  Observation revealed a forward (protruded) head posture, in sitting and 
standing positions.  Both cervical sidebend left and right were moderately impaired 
and all other ranges (protrusion, retraction, flexion and rotation right and left) 
excluding extension were minimally impaired.  There was no movement impairment 
in cervical extension. 
                                                
9 See Appendix 12 for bodychart 
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Results 
 
The following data plots show recorded results obtained during the three phases of the 
current study.  Phase A was a baseline phase, with no intervention applied.  Phase B, 
the intervention phase, included the application of the intervention Simple Contact by 
the practitioner in once-weekly clinical sessions, and prescribed daily homework 
sessions of ideomotor movements.  It was suggested these homework sessions be of 
20 minutes duration.  Phase C was the follow-up phase, in which the weekly clinical 
Simple Contact sessions were withdrawn but the subjects were encouraged to 
maintain their daily homework sessions of ideomotor movements.  In each of the three 
phases the five outcome measures (see Methods) were employed to record any 
changes.  Results were varied between subjects studied, with few clinically important 
changes recorded and variable data not amenable to prediction of trends.  This was 
particularly evident in baseline phases (phase A), where the few data points were 
highly variable. Participant compliance with scheduled data submission days was 
poor in three of the five subjects, and data recorded from all subjects was rendered 
less robust as a result. 
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Subject 1 (S1) 
S1 Quadruple Visual Analogue Scale (QVAS)  
QVAS10 scores for subject 1 over the baseline, treatment and follow-up phases are 
summarised in Figure 1.  The Pain Right Now score is the most variable of the four 
scores; the data recorded in phase A is highly variable making it difficult to establish 
the baseline Pain Right Now score for S1. Phase B and C have less data variability 
and show a general decrease in Pain Right Now mean intensity.  Typical/Average 
Pain reports are also variable during the baseline period leading up to intervention 
when reported pain becomes lower and less variable (Phase B and C).  The range of 
pain reported (Pain At Best and Pain at Worst scores) shows no meaningful change 
during the10 week period.   
 
Figure 1.0 QVAS Pain Intensity Scores pertaining to four subscales of pain intensity measured three times weekly for the 
duration of the trial.  X axis is labelled phase (Week) of Study. Vertical lines mark changes in phase. Phase A is baseline, 
where no intervention is applied. Phase B is the intervention phase, where once weekly clinical treatment sessions occur 
and home, self-directed intervention is applied. During phase C clinical treatment is withdrawn but home based self 
directed intervention remains. 
                                                
10 Quadruple Visual Analogue Scale measures pain levels, where subscales Pain Right Now record pain 
level at the time of measurement, Typical/Average Pain records pain levels typically experienced at 
any time, Pain At Best records the level of pain at its least at any time and Pain at Worst record pain 
levels at their highest at any time. 
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Table 3 shows mean and standard deviation scores for each pain scale of the QVAS 
during each phase of the trial.  The mean (SD) score for Pain Right Now decreased 
from 4.4 (2.2) during phase A to 1.1 (1.1) in phase B, and 1.3 (1.1) in phase C. The 
change from phase A to phase B and change from phase A to phase C exceeds the 
minimum clinically important difference (MCID)11 of 1.5 on the current scale for 
QVAS, suggesting a possible beneficial effect.  Typical/Average Pain decreased from 
3.2 (0.9) during phase A to 2.1 (0.3) in phases B and C, indicating a possible 
beneficial effect due to the intervention, albeit not of clinically important magnitude.  
Pain at Best decreased from 1.4 (0.5) during phase A to 1.0 (0.0) in phases B and C, 
indicating minimal beneficial effect, though such an effect is not clinically important.   
 
   
Table 3: S1QVAS Pain Scale Mean and Standard Deviation 
 Right Now Typical/Average At Best At Worst 
Phase A Mean 4.4 3.2 1.4 9.0 
Phase A Stdev 2.2 0.9 0.5 0.0 
     
Phase B Mean 1.1 2.1 1.0 9.0 
Phase B Stdev 1.1 0.3 0.0 0.0 
     
Phase C Mean 1.3 2.1 1.0 9.0 
Phase C Stdev 1.1 0.3 0.0 0.0 
 
 
 
 
 
 
 
 
 
 
                                                
11 The Minimum Clinically Important Difference is the minimum level of change of an outcome 
measure that is considered to be clinically relevant. 
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S1 Neck Disability Index (NDI) 
 
Figure 1.1 summarises the NDI12 scores for subject 1 over the baseline, treatment and 
follow-up phases. Scores across all three phases are variable.  There is a trend (solid 
black line) for decreasing scores across the ten week period of the trial (Phase A,B 
and C).  This could indicate that the decreasing NDI scores reported by S1 is 
independent of the intervention, i.e. the solid black trendline represents the hypothesis 
that the interventions of Phase B and C do not affect NDI for S1.  The R2 value 
(0.7739) on the trendline fit supports a linear relationship.  An additional trendline is 
fitted to data points from phases B and C (dotted grey line, R2 = 0.4614).  The slopes 
of these trendlines are not clearly different further supporting the hypothesis that the 
interventions are not affecting the NDI scores recorded by S1.  Mean scores are 45.8 
for phase A, 36.0 for phase B, and 31.3 for phase C.  The MCID for NDI is 19 
percentage points (Cleland, Childs, & Whitman, 2008).  Difference in mean scores 
falls within this minimum, suggesting any change was not of sufficient magnitude to 
be clinically important.   
                                                
12 NDI measures disability in activities relating to daily living due to neck pain 
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Figure 1.1 NDI Scores pertaining to perceived disability in daily activity due to neck pain, measured twice weekly during 
phase A, three times weekly during phase B, and once weekly during phase C. X axis is labelled phase (Week) of Study 
.R2 value surrounded by solid black box describes fit of solid black trendline to data from phases A ,B and C.  R2 value 
surrounded by dotted grey line describes fit of dotted grey trendline to data from phases B and C.  Vertical lines mark 
changes in phase. Phase A is baseline, where no intervention is applied. Phase B is the intervention phase, where once 
weekly clinical treatment sessions occur and home, self-directed intervention is required. During phase C clinical 
treatment is withdrawn but home based self directed intervention remains. Gaps in the line are due to this variation of 
frequency of measurement. 
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S1 Patient Specific Functional Scale (PSFS) 
 
Figure 1.2 illustrates the PSFS13 scores for subject 1 over the three phases of the trial; 
baseline, intervention and follow-up.  The overall trend (solid black line, R2 = 0.7005) 
for the entire ten weeks of the trial was an increase, and the fit supports a linear 
relationship, suggesting a lack of effect of the intervention.  No convincing linear 
trendline can be drawn across the data recorded in phase B and C (dotted grey line).  
 
 
 
Figure 1.2: PSFS Scores pertaining to change in perceived ability to perform selected daily tasks. X axis is labelled phase 
(Week) of Study. Measurements were recorded three times weekly in all phases of the trial. Vertical lines mark changes in 
phase. R2 value surrounded by solid black box describes fit of solid black trendline to data from phases A, B and C.  R2 
value surrounded by dotted grey line describes fit of dotted grey trendline to data from phases B and C. Phase A is 
baseline, where no intervention is applied. Phase B is the intervention phase, where once weekly clinical treatment 
sessions occur and home, self-directed intervention is required. During phase C clinical treatment is withdrawn but home 
based self directed intervention remains. 
 
                                                
13 Patient Specific Functional Scale attempts to measure functional status limitation most important to 
the subject. 
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S1 Tampa Scale for Kinesiophobia (TSK) 
 
Figure 1.3 summarises TSK14 scores for subject 1 over the baseline, treatment and 
follow-up phases.  Scores throughout the ten weeks of the trial show high variability.  
It is not possible to infer from this data whether or not an effect on TSK occurred after 
intervention.  
 
 
 
Figure 1.3: TSK Scores pertaining to perceived fear relating to (re)injury due to movement. X axis is labelled phase 
(Week) of Study. Measurements were recorded once weekly during phases A and C and three times weekly during phase 
B. Vertical lines mark changes in phase. Phase A is baseline, where no intervention is applied. Phase B is the intervention 
phase, where once weekly clinical treatment sessions occur and home, self-directed intervention is required. During phase 
C clinical treatment is withdrawn but home based self directed intervention remains. 
 
 
 
 
 
                                                
14 Tampa Scale for Kinesiophobia measures fear of movement (re)injury in chronic pain patients. 
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S1 Fear Avoidance Beliefs Questionnaire (FABQ) 
 
Figure 1.4 summarises FABQ15 scores for subject 1 over the baseline, treatment and 
follow-up phases.  The subscale for physical activity has a mean (SD) of 10.0 (4.2), 
(95% CI = 1.77 to 18.23), and while limited data points in phase A may indicate a 
decrease in this phase, variability of data in subsequent phases do not allow 
conclusions to be drawn as to effect or lack of effect by the interventions of Phase B 
and C.  With the scale for work related activity having variable data and a mean (SD) 
of 11.5 (4.7), (95% CI = 2.29 to 20.71) and all data points being encompassed within 
the confidence interval, any conclusions drawn would likewise be weak.  
 
Figure 1.4: FABQ Scores pertaining to beliefs relating to fear of (re)injury related to movement. X axis is labelled phase 
(Week) of Study. Measurements were recorded once weekly during phases A and C and three times weekly during phase 
B Vertical lines mark changes in phase. Phase A is baseline, where no intervention is applied. Phase B is the intervention 
phase, where once weekly clinical treatment sessions occur and home, self-directed intervention is required. During phase 
C clinical treatment is withdrawn but home based self directed intervention remains. 
 
                                                
15 Fear Avoidance Beliefs Questionnaire measures beliefs relating to fear of movement (re)injury in 
chronic pain patients. 
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S1 Intervention Phase Immediately ‘Before and After’ Treatment 
Visual Analogue Scale (VAS) 
 
Figure 1.5 shows a visual analogue scale for Pain Right Now taken before and after 
clinical treatment with Simple Contact during the three weeks intervention period, 
phase B.  This additional pain rating was recorded in order to ascertain whether there 
was any short term effect of the intervention on Pain Right Now levels.  Pain levels 
before the intervention was applied are constant across the three-week period, with 
pain levels after treatment decreasing by half during the first two treatment sessions, 
and becoming completely absent after the third. The decrease from 2 to 0 on the 
treatment day in the third week of intervention exceeds the MCID of 15 percentage 
points.  Such results may indicate a short term positive effect of the intervention in 
this subject. 
 
 
 
Figure 1.5: Intervention Phase ‘Before and After’ VAS Scores pertaining to perceived Pain Right Now recorded 
immediately before and after Simple Contact intervention/treatment 
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S1 Response Compliance 
 
Figure 1.6 summarises responses compliance16 scores for subject 1 over the baseline, 
treatment and follow-up phases.  Grouped responses (responses for multiple 
scheduled days submitted on the same day) are recorded 6 times, increasing 
dependence of data.  Late responses occur 61 times, ranging from 1 day to 21 days 
late also weakening the reliability of the data.  Only seven responses were submitted 
on the scheduled date by S1.   
 
Figure 1.6: Measurement Responses; indicating the scheduled (target) day of the trial each set of measurements was to be 
submitted plotted against the actual (recorded) day each response was submitted. Multiple lines converging on 1 recorded 
point (grouped data) indicates multiple days’ worth of measurement data submitted on one day. Inclined lines indicate 
late responses. Declined lines indicate early responses. Steeper slopes indicate a longer time before or after the target date 
responses were submitted. 
 
 
 
 
                                                
16 Response Compliance meaning the degree to which subjects submitted measurement data on the 
dates scheduled.  Tardy or early responses indicate a lack of compliance. 
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Subject 2 (S2) 
 
S2 Quadruple Visual Analogue Scale (QVAS) 
 
QVAS17 scores for subject 2 over the baseline, treatment and follow-up phases are 
summaried in Figure 2.0.  The Pain Right Now scale is the most variable of the four 
scales, making it difficult to establish a baseline for phase A.  Variability increases 
leading up to and into phase B.  Phase C is less variable than either of the preceding 
two phases, however overall variability of Pain Right Now data does not allow 
assumptions as to any effect occurring.  Typical/Average Pain demonstrates an 
apparent decrease from phase A to phases B and C, but variability of data would 
preclude a good fit of any trendlines. As such no conclusion regarding effect may be 
draw for this subscale.  Pain at Best remains constant at 8 throughout the trial, 
suggesting no effect of the intervention.  Pain at Worst decreases from 2 in the first 
measurement to 1 in the second, where it remains throughout the remainder of the 
trial. 
                                                
17 Quadruple Visual Analogue Scale measures pain levels, where subscales Pain Right Now record pain 
level at the time of measurement, Typical/Average Pain records pain levels typically experienced at 
any time, Pain At Best records the level of pain at its least at any time and Pain at Worst record pain 
levels at their highest at any time. 
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Figure 2.0: QVAS Pain Intensity Scores pertaining to four subscales of pain intensity measured three times weekly for the 
duration of the trial. Vertical lines mark changes in phase. Phase A is baseline, where no intervention is applied. Phase B 
is the intervention phase, where once weekly clinical treatment sessions occur and home, self-directed intervention is 
applied. During phase C clinical treatment is withdrawn but home based self directed intervention remains. 
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Table 4 shows mean and standard deviation scores for each scale during each phase of 
the 9 week trial.  Pain Right Now shows an increase in mean (SD) from phase A to 
phase B, changing from 2.3 (1.2) to 3.6 (1.5), decreasing to 2.2 (0.7) in phase C.  
These changes do not exceed the MCID18 of 15 percentage points, suggesting changes 
occurring were not clinically important.  Means for Typical/Average Pain decrease in 
phases B and C in comparison to phase A, but do not exceed 15 percentage points 
required for the MCID, suggesting changes recorded were not of clinically important 
magnitude.  
 
 
Table 4: S2 QVAS Pain Scale Mean and Standard Deviation 
 Right Now Typical/Average At Best At Worst 
Phase A Mean 2.3 2.7 1.1 8.0 
Phase A Stdev 1.2 0.7 0.3 0.0 
     
Phase B Mean 3.6 1.6 1.0 8.0 
Phase B Stdev 1.5 0.7 0.0 0.0 
     
Phase C Mean 2.2 1.3 1.0 8.0 
Phase C Stdev 0.7 0.5 0.0 0.0 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
18The Minimum Clinically Important Difference is the minimum level of change of an outcome 
measure that is considered to be clinically relevant 
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S2 Neck Disability Index (NDI) 
 
NDI19 scores for subject 2 over the baseline, treatment and follow-up phases are 
summarised in Figure 2.1 There is a trend (solid black line) for increasing scores 
across the nine week period of the trial (Phase A,B and C).  This could indicate that 
the increasing NDI scores reported by S2 is independent of the intervention, i.e. the 
solid black trendline represents the hypothesis that the interventions of Phase B and C 
do not affect NDI for S2 . The R2 value (0.2308) is low, but suggests the relationship 
between X and Y variables may be linear.   A second trendline (dotted grey line) was 
plotted for data occurring in phase B and C.  The R2 value (0.043) is too low to be 
able to conclude whether there was an effect due to the intervention.  Mean (SD) 
scores increase from 48.0 (4.7) in phase A to 52.2 (2.5) and 50.7 (2.3) in phases B and 
C respectively, not exceeding the MCID of 19 percentage points, such that any 
change subsequent to phase A must be considered trivial.  
 
 
                                                
19 NDI measures disability in activities relating to daily living due to neck pain 
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Figure 2.1: NDI Scores pertaining to perceived disability in daily activity due to neck pain, measured twice weekly during 
phase A, three times weekly during phase B, and once weekly during phase C. X axis is labelled phase (Week) of Study. R2 
value surrounded by solid black box describes fit of solid black trendline to data from phases A ,B and C.  R2 value 
surrounded by dotted grey line describes fit of dotted grey trendline to data from phases B and C.  Vertical lines mark 
changes in phase. Phase A is baseline, where no intervention is applied. Phase B is the intervention phase, where once 
weekly clinical treatment sessions occur and home, self-directed intervention is required. During phase C clinical 
treatment is withdrawn but home based self directed intervention remains. Gaps in the line are due to this variation of 
frequency of measurement. 
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S2 Patient Specific Functional Scale (PSFS) 
 
PSFS20 scores for subject 2 over the baseline, treatment and follow-up phases are 
summaried in Figure 2.2.  There is a trend (solid black line) for decreasing scores 
across the nine week period of the trial (Phase A,B and C).  This could indicate that 
the decreasing PSFS scores reported by S2 is independent of the intervention, i.e. the 
solid black trendline represents the hypothesis that the interventions of Phase B and C 
do not affect PSFS for S2.   The R2 value (R2 = 0.292) is weak but suggests a linear 
relationship between X and Y variables.  A trendline (dotted grey line) is fitted to data 
from phases B and C, but its low R2 value (R2 = 0.292) does not allow conclusions as 
to whether there was an effect. 
 
 
 
 
                                                
20 Patient Specific Functional Scale attempts to measure functional status limitation most important to 
the patient. 
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Figure 2.2: PSFS Scores pertaining to change in perceived ability to perform selected daily tasks. Measurements were 
recorded three times weekly in all phases of the trial. Vertical lines mark changes in phase. R2 value surrounded by solid 
black box describes fit of solid black trendline to data from phases A ,B and C.  R2 value surrounded by dotted grey line 
describes fit of dotted grey trendline to data from phases B and C. Phase A is baseline, where no intervention is applied. 
Phase B is the intervention phase, where once weekly clinical treatment sessions occur and home, self-directed 
intervention is required. During phase C clinical treatment is withdrawn but home based self directed intervention 
remains. 
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S2 Tampa Scale for Kinesiophobia (TSK) 
 
TSK21 scores for subject 2 over the baseline, treatment and follow-up phases are 
summarised in Figure 2.3.  There is a trend (solid black line, R2 = 0.6486) for 
increasing scores across the nine week period of the trial (Phase A,B and C).  This 
could indicate that the increasing TSK scores reported by S2 is independent of the 
intervention, i.e. the solid black trendline represents the hypothesis that the 
interventions of Phase B and C do not affect TSK for S2.  The R2 value of 0.6486 
suggests a linear relationship between X and Y variables. A trendline fitted to phase B 
and C data (dotted grey line, R2 = 0.6519) does not demonstrate a difference in slope 
of sufficient magnitude to suggest an effect of the intervention, supporting the 
hypothesis that change in scores for TSK is independent of the intervention, an no 
effect occurred.   
 
 
 
                                                
21 Tampa Scale for Kinesiophobia measures fear of movement (re)injury in chronic pain patients 
 50 
 
 
Figure 2.3: TSK Scores pertaining to perceived fear relating to (re)injury due to movement. Measurements were 
recorded once weekly during phases A and C and three times weekly during phase B. Vertical lines mark changes in 
phase.  R2 value surrounded by solid black box describes fit of solid black trendline to data from phases A ,B and C.  R2  
value surrounded by dotted grey line describes fit of dotted grey trendline to data from phases B and C. Phase A  is 
baseline, where no intervention is applied. Phase B is the intervention phase, where once weekly clinical treatment 
sessions occur and home, self directed intervention is required. During phase C clinical treatment is withdrawn but home 
based self directed intervention remains. 
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S2 Fear Avoidance Beliefs Questionnaire (FABQ) 
 
FABQ22 scores for subject 2 over the baseline, treatment and follow-up phases are 
summarised in Figure 2.4.  Variable data occurring in all phases and in both subscales 
of the measure preclude interpretation and subsequent conclusion as to whether an 
effect was present.  Further, the lack of data points falling outside the phase A 
confidence interval (95% CI = 9.86 to 25.54) may suggest that all data points in 
phases B and C occurred by chance, whether or not an effect occurred.  
 
 
 
Figure 2.4: FABQ Scores pertaining to beliefs relating to fear of (re)injury related to movement.  Measurements were 
recorded once weekly during phases A and C and three times weekly during phase B Vertical lines mark changes in 
phase. Phase A is baseline, where no intervention is applied. Phase B is the intervention phase, where once weekly clinical 
treatment sessions occur and home, self-directed intervention is required. During phase C clinical treatment is withdrawn 
but home based self directed intervention remains. 
 
                                                
22 Fear Avoidance Beliefs Questionnaire measures beliefs relating to fear of movement (re)injury in 
chronic pain patients 
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S2 Intervention Phase Immediately ‘Before and After’ Treatment 
Visual Analogue Scale (VAS) 
 
Figure 2.5 shows a visual analogue scale for Pain Right Now taken before and after 
clinical treatment with Simple Contact during the three weeks intervention period, 
phase B.  This additional pain rating was recorded in order to ascertain whether there 
was any short term effect of the intervention on Pain Right Now levels  Before scores 
decrease from 4 in week one to 3 and 2 in weeks two and three respectively.  After 
scores are 2 in both weeks one and two, and 1 in week three.  The difference in score 
recorded in week 1 from before to after exceed the MCID of 15 percentage points for 
VAS.  The change in before scores from week 1 to week 3 also exceeds the MCID of 
15%.  It is thus possible that there is a short term beneficial effect attributable to the 
intervention.  
 
 
 
Figure 2.5: Intervention Phase ‘Before and After’ VAS Scores pertaining to perceived Pain Right Now recorded 
immediately before and after Simple Contact intervention/treatment 
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S2 Response Compliance 
 
Responses compliance23 scores for subject 1 over the baseline, treatment and follow-
up phases is summarised in Figure 2.6.  Grouped responses occurred once, and there 
were two submissions occurring after the scheduled date, one of 1 day and one of 2 
days.  It is likely that inaccurate submission will have affected accuracy of scores 
collected subsequent to late submission, rendering conclusions drawn weaker. 
 
 
Figure 2.6: Measurement Responses; indicating the scheduled (target) day of the trial each set of measurements was to be 
submitted plotted against the actual (recorded) day each response was submitted. Multiple lines converging on  
1 recorded point (grouped data) indicates multiple days’ worth of measurement data submitted on one day. Inclined lines 
indicate late responses. Declined lines indicate early responses. Steeper slopes indicate a longer time before or after the 
target date responses were submitted. 
 
 
 
 
                                                
23 Response Compliance meaning the degree to which subjects submitted measurement data on the 
dates scheduled.  Tardy or early responses indicate a lack of compliance. 
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Subject 3 (S3) 
 
S3 Quadruple Visual Analogue Scale (QVAS) 
 
QVAS24 scores for subject 3 over the baseline, treatment and follow-up phases are 
summarised in Figure 3.0.  Variability is evident in all phases for all subscales, but is 
particularly apparent in the phase C.  Trendlines fitted to data recorded in figure 3.0 
would have a poor fit due to the variability in phase C and for this reason such 
analysis is not warranted.  Visual inspection suggests Typical/Average Pain decreased 
at the end of phase B and early in phase C, before increasing.  It is not possible to 
ascertain whether or not an effect is represented in the results reproduced in this 
figure. 
 
Figure 3.0: QVAS Pain Intensity Scores pertaining to four subscales of pain intensity measured three times weekly for the 
duration of the trial. Vertical lines mark changes in phase. Phase A is baseline, where no intervention is applied. Phase B 
is the intervention phase, where once weekly clinical treatment sessions occur and home, self-directed intervention is 
applied. During phase C clinical treatment is withdrawn but home based self directed intervention remains. 
                                                
24 Quadruple Visual Analogue Scale measures pain levels, where subscales Pain Right Now record pain 
level at the time of measurement, Typical/Average Pain records pain levels typically experienced at 
any time, Pain At Best records the level of pain at its least at any time and Pain at Worst record pain 
levels at their highest at any time. 
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Table 5 shows mean and standard deviations calculated for each pain scale during 
each phase of the nine week trial.  Mean (SD) scores for Typical/Average Pain 5.1 
(1.6) in phase C from 7.2 (0.4), (95% CI = 6.42 to 7.98) in phase A.  In phase C, 
seven data points fall below the phase A confidence interval, while in phase B one 
does.  The difference in mean scores seen in the Typical/Average Pain subscale 
occurring in excess of 15 percentage points (1.5 on the current scale) from phase A to 
phase C suggests a clinically important change.  The event of points falling outside 
the phase A confidence interval for the Typical/Average Pain subscale suggest these 
values did not occur by chance, however it is not possible to suggest this is an effect 
of the intervention.   
 
 
Table 5: S3 QVAS Pain Scale Mean and Standard Deviation 
 Right Now Typical/Average At Best At Worst 
Phase A Mean 8.1 7.2 4.0 8.7 
Phase A Stdev 0.8 0.4 0.0 0.5 
     
Phase B Mean 7.3 6.9 3.9 8.8 
Phase B Stdev 0.5 1.2 0.4 0.5 
     
Phase C Mean 7.2 5.1 3.8 8.3 
Phase C Stdev 0.7 1.6 1.3 0.5 
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S3 Neck Disability Index (NDI) 
 
NDI25 scores for subject 3 over the baseline, treatment and follow-up phases are 
summarised in Figure 3.1.  Scores across all three phases are variable.  There is a 
trend (solid black line) for decreasing scores across the nine week period of the trial 
(Phase A,B and C).  This could indicate that the decreasing NDI scores reported by S3 
is independent of the intervention, i.e. the solid black trendline represents the 
hypothesis that the interventions of Phase B and C do not affect NDI for S3. The R2 
value (0.4914) on the trendline fit supports a linear relationship between X and Y 
variables. An additional trendline is fitted to data points from phases B and C (dotted 
grey line, R2 = 0.2963). The slopes of these trendlines are not clearly different which 
would support the hypothesis that the intervention is not affecting the NDI scores 
recorded by S3, however the low R2 value of phase B and C data does not allow a 
conclusion as to the presence or absence of an effect.  Further, decreases in mean 
(SD) scores in phase A of 38.3 (4.1) to 33.6 (3.4) in phase B and 26.7 (2.3) in phase C 
do not exceed the MCID of 19% indicating any change in disability levels recorded 
were not clinically important.  
 
                                                
25 NDI measures disability in activities relating to daily living due to neck pain 
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Figure 3.1: NDI Scores pertaining to perceived disability in daily activity due to neck pain, measured twice weekly during 
phase A, three times weekly during phase B, and once weekly during phase C. R2 value surrounded by solid black box 
describes fit of solid black trendline to data from phases A ,B and C.  R2 value surrounded by dotted grey line describes 
fit of dotted grey trendline to data from phases B and C.  Vertical lines mark changes in phase. Phase A is baseline, where 
no intervention is applied. Phase B is the intervention phase, where once weekly clinical treatment sessions occur and 
home, self-directed intervention is required. During phase C clinical treatment is withdrawn but home based self directed 
intervention remains. Gaps in the line are due to this variation of frequency of measurement. 
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S3 Patient Specific Functional Scale (PSFS) 
 
PSFS26 scores for subject 3 over the three phases of the trial; baseline, intervention 
and follow-up are illustrated in Figure 3.2.  There is a trend (solid black line) for 
decreasing scores across the nine week period of the trial (Phase A,B and C).  This 
could indicate that the decreasing PSFS scores reported by S3 is independent of the 
intervention, i.e. the solid black trendline represents the hypothesis that the 
interventions of Phase B and C do not affect PSFS for S3.   The R2 value (R2 = 
0.0424) weak and does not suggest a linear relationship between X and Y variables.  
A trendline (dotted grey line) is fitted to data from phases B and C, but due to its low 
R2 value (R2 = 0.2497) it is not possible to suggest whether there is effect due to the 
intervention. 
 
 
 
 
                                                
26 Patient Specific Functional Scale attempts to measure functional status limitation most important to 
the patient. 
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Figure 3.2: PSFS Scores pertaining to change in perceived ability to perform selected daily tasks. Measurements were 
recorded three times weekly in all phases of the trial. Vertical lines mark changes in phase. R2 value surrounded by solid 
black box describes fit of solid black trendline to data from phases A ,B and C.  R2 value surrounded by dotted grey line 
describes fit of dotted grey trendline to data from phases B and C. Phase A is baseline, where no intervention is applied. 
Phase B is the intervention phase, where once weekly clinical treatments sessions occur and home, self-directed  
intervention is required. During phase C clinical treatment is withdrawn but home based self directed intervention 
remains. 
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S3 Tampa Scale for Kinesiophobia (TSK) 
 
TSK27 scores for subject 3 over the baseline, treatment and follow-up phases are 
summarised in Figure 3.3.  Scores across phases B and C are variable.  There is a 
trend (solid black line) for decreasing scores across the nine week period of the trial 
(Phase A,B and C).  This could indicate that the decreasing TSK scores reported by 
S3 are independent of the intervention, i.e. the solid black trendline represents the 
hypothesis that the interventions of Phase B and C do not affect TSK for S3. The R2 
value (0.0079) on the trendline fit does not suggest a linear relationship between X 
and Y variables. An additional trendline is fitted to data points from phases B and C 
(dotted grey line, R2 = 0.2704). R2 values are too low to make conclusions as to the 
presence of an effect. 
 
  
 
 
 
                                                
27 Tampa Scale for Kinesiophobia measures fear of movement (re)injury in chronic pain patients. 
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Figure 3.3: TSK Scores pertaining to perceived fear relating to (re)injury due to movement. Measurements were 
recorded once weekly during phases A and C and three times weekly during phase B. Vertical lines mark changes in 
phase.  R2 value surrounded by solid black box describes fit of solid black trendline to data from phases A ,B and C.  R2  
value surrounded by dotted grey line describes fir of dotted grey trendline to data from phases B and C. Phase A  is 
baseline, where no intervention is applied. Phase B is the intervention phase, where once weekly clinical treatments 
sessions occur and home, self directed intervention is required. During phase C clinical treatment is withdrawn but home 
based self directed intervention remains. 
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S3 Fear Avoidance Beliefs Questionnaire (FABQ) 
 
FABQ28 scores for subject 3 over the baseline, treatment and follow-up phases are 
summarised in Figure 3.4.  Variable data occurring in all phases and in both subscales 
of the measure preclude interpretation and subsequent conclusion as to whether an 
effect occurred.  
 
 
 
Figure 3.4: FABQ Scores pertaining to beliefs relating to fear of (re)injury related to movement.  Measurements were 
recorded once weekly during phases A and C and three times weekly during phase B Vertical lines mark changes in 
phase. Phase A is baseline, where no intervention is applied. Phase B is the intervention phase, where once weekly clinical 
treatments sessions occur and home, self-directed intervention is required. During phase C clinical treatment is 
withdrawn but home based self directed intervention remains. 
 
 
 
                                                
28 Fear Avoidance Beliefs Questionnaire measures beliefs relating to fear of movement (re)injury in 
chronic pain patients. 
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S3 Intervention Phase Immediately ‘Before and After’ Treatment 
Visual Analogue Scale (VAS) 
 
Figure 3.5 shows a visual analogue scale for Pain Right Now taken before and after 
clinical treatment with Simple Contact during the three weeks intervention period, 
phase B. This additional pain rating was recorded in order to ascertain whether there 
was any short term effect of the intervention on Pain Right Now levels.  In the first 
week, scores before and after treatment were 8.  In both subsequent weeks, scores 
decreased to 7 before and after treatment.  This decrease is not sufficient to exceed the 
MCID of 15% for VAS pain scales, and it is not possible to allude to a short-term 
treatment effect.  
 
 
 
Figure 3.5: Intervention Phase ‘Before and After’ Scores pertaining to perceived Pain Right Now recorded immediately 
before and after Simple Contact intervention/treatment 
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S3 Response Compliance 
 
Responses compliance29 scores for subject 3 over the baseline, treatment and follow-
up phases are summarised in Figure 3.6.  Grouped responses occurred six times.  
Responses were submitted late 54 times, ranging from 1 to 6 days late.  Early 
responses occurred twice, each 4 days ahead of the scheduled date.  Such a lack of 
compliance will have undermined integrity of data recorded.  This result will have 
implications upon conclusions as to effect of the intervention. 
 
 
Figure 3.6: Measurement Responses; indicating the scheduled (target) day of the trial each set of measurements was to be 
submitted plotted against the actual (recorded) day each response was submitted. Multiple lines converging on 1 recorded 
point (grouped data) indicates multiple days’ worth of measurement data submitted on one day. Inclined lines indicate 
late responses. Declined lines indicate early responses. Steeper slopes indicate a longer time before or after the target date 
responses were submitted. 
                                                
29 Response Compliance meaning the degree to which subjects submitted measurement data on the 
dates scheduled.  Tardy or early responses indicate a lack of compliance. 
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Subject 4 (S4) 
 
S4 Quadruple Visual Analogue Scale (QVAS) 
 
QVAS30 scores for subject 4 over the baseline, treatment and follow-up phases are 
summarised in Figure 4.0.  Pain Right Now scores are variable and a data point is 
missing in phase B.  Typical/Average Pain is constant over phase A but becomes 
variable in the proceeding two phases.  Pain at Best does not vary over the nine weeks 
of the trial.  Pain at Worst, after initially decreasing by 1 point, stays level through the 
remainder of the trial. Due to variability of data it is not possible to draw conclusions 
as to the presence or absence of an effect for any subscale.   
 
 
                                                
30 Quadruple Visual Analogue Scale measures pain levels, where subscales Pain Right Now record pain 
level at the time of measurement, Typical/Average Pain records pain levels typically experienced at 
any time, Pain At Best records the level of pain at its least at any time and Pain at Worst record pain 
levels at their highest at any time. 
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Figure 4.0: QVAS Pain Intensity Scores pertaining to four subscales of pain intensity measured three times weekly for the 
duration of the trial. Vertical lines mark changes in phase. Phase A is baseline, where no intervention is applied. Phase B 
is the intervention phase, where once weekly clinical treatments sessions occur and home, self-directed intervention is 
applied. During phase C clinical treatment is withdrawn but home based self directed intervention remains. 
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Table 6 shows mean and standard deviation scores calculated for each pain scale 
during each of the three phases of the 9 week trial.  None of the mean scores have 
variation of sufficient magnitude to exceed the 15 percentage points required to reach 
the MCID31.   
 
 
Table 6: S4 QVAS Pain Scale Mean and Standard Deviation 
 Right Now Typical/Average At Best At Worst 
Phase A Mean 2.7 2.0 0.0 3.1 
Phase A Stdev 0.7 0.0 0.0 0.3 
     
Phase B Mean 1.6 1.8 0.0 3.0 
Phase B Stdev 0.7 0.5 0.0 0.0 
     
Phase C Mean 1.4 2.2 0.0 3.0 
Phase C Stdev 0.5 0.7 0.0 0.0 
 
                                                
31 The Minimum Clinically Important Difference is the minimum level of change of an outcome 
measure that is considered to be clinically relevant 
 68 
S4 Neck Disability Index (NDI) 
 
NDI32 scores for subject 4 over the baseline, treatment and follow-up phases are 
summarised in Figure 4.1.  Data within phase A was the most variable of the three 
phases, although variable data was apparent in every phase.  This variability suggests 
the fit of trendlines would be poor and does not allow conclusions to be drawn 
regarding existence of an effect.  The mean (SD) for phase A was 23.7 (3.9), (95% CI 
= 16.06 to 31.34) for phase B 19.8 (1.7) and for phase C 20.7 (1.2).  Decreases 
satisfying an MCID33 of 19 percentage points were not achieved such that any change 
observed is not clinically important.  
 
 
 
 
 
 
                                                
32 NDI measures disability in activities relating to daily living due to neck pain 
33 The Minimum Clinically Important Difference is the minimum level of change of an outcome 
measure that is considered to be clinically relevant 
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Figure 4.1: NDI Scores pertaining to perceived disability in daily activity due to neck pain, measured twice weekly during 
phase A, three times weekly during phase B, and once weekly during phase C.  Vertical lines mark changes in phase. 
Phase A is baseline, where no intervention is applied. Phase B is the intervention phase, where once weekly clinical 
treatments sessions occur and home, self-directed intervention is required. During phase C clinical treatment is 
withdrawn but home based self directed intervention remains. Gaps in the line are due to this variation of frequency of 
measurement. 
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S4 Patient Specific Functional Scale (PSFS) 
 
PSFS34 scores for subject 4 over the three phases of the trial; baseline, intervention 
and follow-up are summarised in Figure 4.2.  Scores recorded in phases A and B are 
variable, while phase C shows less variability. There is a missing data point in phase 
B.  A trendline fitted to this data would be of a poor fit, and it is not possible to 
conclude whether an effect occurred.    
 
Figure 4.2: PSFS Scores pertaining to change in perceived ability to perform selected daily tasks. Measurements were 
recorded three times weekly in all phases of the trial. Vertical lines mark changes in phase. Phase A is baseline, where no 
intervention is applied. Phase B is the intervention phase, where once weekly clinical treatments sessions occur and home, 
self-directed intervention is required. During phase C clinical treatment is withdrawn but home based self directed 
intervention remains. 
 
 
 
 
                                                
34 Patient Specific Functional Scale attempts to measure functional status limitation most important to 
the patient. 
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S4 Tampa Scale for Kinesiophobia (TSK) 
 
TSK35 scores for subject 4 over the baseline, treatment and follow-up phases are 
summarised in Figure 4.3.  There is a trend (solid black line) for increasing scores 
across the nine week period of the trial (Phase A,B and C).  This could indicate that 
the increasing TSK scores reported by S4 is independent of the intervention, i.e. the 
solid black trendline represents the hypothesis that the interventions of Phase B and C 
do not affect TSK for S4. The R2 value (0.091) is too low to allow comparison to be 
made, however second trendline (dotted grey line R2 = 0.8138) plotted for data 
occurring in phase B and C suggests a decrease in scores after an apparent increase 
over phase A. 
 
Figure 4.3: TSK Scores pertaining to perceived fear relating to (re)injury due to movement. Measurements were 
recorded once weekly during phases A and C and three times weekly during phase B. Vertical lines mark changes in 
phase. R2 value surrounded by solid black box describes fit of solid black trendline to data from phases A ,B and C.  R2 
value surrounded by dotted grey line describes fit of dotted grey trendline to data from phases B and C.  Phase A is 
baseline, where no intervention is applied. Phase B is the intervention phase, where once weekly clinical treatments 
sessions occur and home, self-directed intervention is required. During phase C clinical treatment is withdrawn but home 
based self directed intervention remains. 
                                                
35 Tampa Scale for Kinesiophobia measures fear of movement (re)injury in chronic pain patients. 
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S4 Fear Avoidance Beliefs Questionnaire (FABQ) 
 
FABQ36 scores for subject 4 over the baseline, treatment and follow-up phases are 
summarised in Figure 4.4.   There is a trend (solid grey line, R2 = 0.3142 for the Work 
Related Activity Subscale, dotted black line, R2 = 0.1346 for the Physical Activity 
subscale) for increasing scores across the nine week period of the trial (Phase A,B and 
C).  This could indicate that the increasing FABQ scores reported by S4 is 
independent of the intervention, i.e. the solid black trendline represents the hypothesis 
that the interventions of Phase B and C do not affect subscales for FABQ for S4. The 
R2 value of 0.314 for the Physical Activity subscale suggests a linear relationship 
between X and Y variables. Trendlines are also fitted to phase B and C data (dotted 
grey line, R2 = 0.0953 for the Physical Activity subscale and solid black line R2 = 
0.2905 for the Work Related Activity subscale).  The low R2 values for both subscales 
do not allow for a conclusion as to whether or not  there was an effect. 
 
                                                
36 Fear Avoidance Beliefs Questionnaire measures beliefs relating to fear of movement (re)injury in 
chronic pain patients. 
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Figure 4.4: FABQ Scores pertaining to beliefs relating to fear of (re)injury related to movement.  Measurements were 
recorded once weekly during phases A and C and three times weekly during phase B Vertical lines mark changes in 
phase. R2 value surrounded by solid grey box describes fit of solid grey trendline to data from phases A ,B and C for the 
Work Related Activity subscale.  R2 value surrounded by a dotted black line describes fit of dotted black trendline to data 
from phases A, B and C for the Physical Activity subscale.  R2 value surrounded by dotted grey line describes fit of dotted 
grey trendline to data from phases B and C for the Physical Activity subscale.  R2 value surrounded by a solid black line 
describes fit of trendline to data from phases B and C for Work Related Activity subscale.  Phase A is baseline, where no 
intervention is applied. Phase B is the intervention phase, where once weekly clinical treatments sessions occur and home, 
self-directed intervention is required. During phase C clinical treatment is withdrawn but home based self directed 
intervention remains. 
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S4 Intervention Phase Immediately ‘Before and After’ Treatment 
Visual Analogue Scale (VAS) 
 
Figure 4.5 shows a visual analogue scale for Pain Right Now taken before and after 
clinical treatment with Simple Contact during the three weeks intervention period, 
phase B.  This additional pain rating was recorded in order to ascertain whether there 
was any short term effect of the intervention on Pain Right Now levels   Results 
showing no change across the three weeks of the intervention phase indicate that there 
was no short-term effect of the intervention for this subject. 
 
 
 
Figure 4.5: Intervention Phase ‘Before and After’ Scores pertaining to perceived Pain Right Now recorded immediately 
before and after Simple Contactt intervention/treatment 
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S4 Response Compliance 
 
Responses compliance37 scores for subject 4 over the baseline, treatment and follow-
up phases are summarised in Figure 4.6.  Grouped data occurred three times.  Fifty-
three late responses were recorded, occurring between 1 and 10 days late.  There was 
also one missed submission.  Such errors in submission of measures decrease integrity 
of recorded data, rendering conclusions drawn potentially inaccurate. 
 
 
Figure 4.6: Measurement Responses; indicating the scheduled (target) day of the trial each set of measurements was to be 
submitted plotted against the actual (recorded) day each response was submitted. Multiple lines converging on 1 recorded 
point (grouped data) indicates multiple days’ worth of measurement data submitted on one day. Inclined lines indicate 
late responses. Declined lines indicate early responses. Steeper slopes indicate a longer time before or after the target date 
responses were submitted. 
                                                
37 Response Compliance meaning the degree to which subjects submitted measurement data on the 
dates scheduled.  Tardy or early responses indicate a lack of compliance. 
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Subject 5 (S5) 
 
S5 Quadruple Visual Analogue Scale (QVAS) 
 
QVAS38 scores for subject 5 over the baseline, treatment and follow-up phases are 
summarised in Figure 5.0.  Pain Right Now and Typical/Average Pain subscales 
demonstrate variability over the first two phases, but both subscales become more 
stable in phase C.  Due to variability of data it is not possible to draw conclusions as 
to whether or not an effect occurred. 
 
 
 
Figure 5.0: QVAS Pain Intensity Scores pertaining to four subscales of pain intensity measured three times weekly for the 
duration of the trial. Vertical lines mark changes in phase. Phase A is baseline, where no intervention is applied. Phase B 
is the intervention phase, where once weekly clinical treatments sessions occur and home, self-directed intervention is 
applied. During phase C clinical treatment is withdrawn but home based self directed intervention remains. 
                                                
38 Quadruple Visual Analogue Scale measures pain levels, where subscales Pain Right Now record pain 
level at the time of measurement, Typical/Average Pain records pain levels typically experienced at 
any time, Pain At Best records the level of pain at its least at any time and Pain at Worst record pain 
levels at their highest at any time. 
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Table 7 summarises mean and standard deviation calculated for each subscale during 
each phase of the nine week trail. The mean (SD) for phase A for subscales Pain 
Right Now, Typical/Average Pain and Pain at Worst are 1.0 (1.2), 1.6 (0.7) and 8.6 
(0.7), (95% CI = 0.00 to 3.35; 0.23 to 2.97; 7.23 to 9.97).  No subsequent phase mean 
in any subscale exceeds 15 percentage points required to obtain the MCID39, such that 
any decrease in levels recorded is not of sufficient magnitude to be considered 
clinically important.   
 
 
Table 7: S5 QVAS Pain Scale Mean and Standard Deviation 
 Right Now Typical/Average At Best At Worst 
Phase A Mean 1.0 1.6 0.0 8.6 
Phase A Stdev 1.2 0.7 0.0 0.7 
     
Phase B Mean 1.4 1.3 0.1 9.0 
Phase B Stdev 0.5 0.7 0.3 0.0 
     
Phase C Mean 0.2 0.9 0.0 8.3 
Phase C Stdev 0.4 0.3 0.0 0.9 
 
 
 
 
 
 
 
                                                
39 The Minimum Clinically Important Difference is the minimum level of change of an outcome 
measure that is considered to be clinically relevant 
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S5 Neck Disability Index (NDI) 
 
NDI40 scores for subject 5 over the baseline, treatment and follow-up phases are 
summarised in Figure 5.1.  Due to variability in scores across all phases any trendline 
plotted would not fit data well, and as such was excluded.  Variability of data 
precludes ascertaining whether any effect is present.  The mean (SD) for phase A is 
22.0 (2.8), (95%CI = 16.51 to 27.49) to 16.7 (3.1) in phase C.  This decrease in mean 
is not sufficient to satisfy an MCID41 of 19 percentage points, such that the decrease 
in mean NDI scores cannot be considered clinically important.   
 
Figure 5.1: NDI Scores pertaining to perceived disability in daily activity due to neck pain, measured twice weekly during 
phase A, three times weekly during phase B, and once weekly during phase C. Vertical lines mark changes in phase. 
Phase A is baseline, where no intervention is applied. Phase B is the intervention phase, where once weekly clinical 
treatments sessions occur and home, self-directed intervention is required. During phase C clinical treatment is 
withdrawn but home based self directed intervention remains. Gaps in the line are due to variation of frequency of 
measurement. 
                                                
40 NDI measures disability in activities relating to daily living due to neck pain 
41 The Minimum Clinically Important Difference is the minimum level of change of an outcome 
measure that is considered to be clinically relevant 
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S5 Patient Specific Functional Scale 
 
PSFS42 scores for subject 5 over the three phases of the trial; baseline, intervention 
and follow-up are illustrated in Figure 5.2.  There is a trend (solid black line, R2 = 
0.061) for increasing scores across the nine week period of the trial (Phase A,B and 
C).  This could indicate that the increasing PSFS scores reported by S5 is independent 
of the intervention, i.e. the solid black trendline represents the hypothesis that the 
interventions of Phase B and C do not affect PSFS for S5.  A trendline (dotted grey 
line, R2 = 0.3529) is fitted to data from phases B and C.  The low R2 value of both 
lines does not allow for the presence or absence of an effect to be identified. 
 
Figure 5.2: PSFS Scores pertaining to change in perceived ability to perform selected daily tasks. Measurements were 
recorded three times weekly in all phases of the trial. Vertical lines mark changes in phase. R2 value surrounded by solid 
black box describes fit of solid black trendline to data from phases A ,B and C.  R2 value surrounded by dotted grey line 
describes fit of dotted grey trendline to data from phases B and C. Phase A is baseline, where no intervention is applied. 
Phase B is the intervention phase, where once weekly clinical treatments sessions occur and home, self-directed 
intervention is required. During phase C clinical treatment is withdrawn but home based self directed intervention 
remains. 
                                                
42 Patient Specific Functional Scale attempts to measure functional status limitation most important to 
the patient. 
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S5 Tampa Scale for Kinesiophobia (TSK) 
 
TSK43 scores for subject 5 over the baseline, treatment and follow-up phases are 
summarised in Figure 5.3.  There is a trend (solid black line, R2 = 0.7133) for 
decreasing scores across the nine week period of the trial (Phase A,B and C).  This 
could indicate that the decreasing TSK scores reported by S5 is independent of the 
intervention, i.e. the solid black trendline represents the hypothesis that the 
interventions of Phase B and C do not affect TSK for S5.  The R2 value of 0.7133 
suggests a linear relationship between X and Y variables. A trendline fitted to phase B 
and C data (dotted grey line, R2 = 0.4093) does not demonstrate a difference in slope 
of sufficient magnitude to suggest an effect of the intervention, supporting the 
hypothesis that change in scores for TSK is independent of the intervention and no 
effect was observed.   
  
 
 
 
                                                
43 Tampa Scale for Kinesiophobia measures fear of movement (re)injury in chronic pain patients. 
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Figure 5.3: TSK Scores pertaining to perceived fear relating to (re)injury due to movement. Measurements were 
recorded once weekly during phases A and C and three times weekly during phase B. Vertical lines mark changes in 
phase. R2 value surrounded by solid black box describes fit of solid black trendline to data from phases A ,B and C.  R2 
value surrounded by dotted grey line describes fit of dotted grey trendline to data from phases B and C.  Phase A is 
baseline, where no intervention is applied. Phase B is the intervention phase, where once weekly clinical treatments 
sessions occur and home, self-directed intervention is required. During phase C clinical treatment is withdrawn but home 
based self directed intervention remains. 
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S5 Fear Avoidance Beliefs Questionnaire (FABQ) 
 
FABQ44 scores for subject 5 over the baseline, treatment and follow-up phases are 
summarised in Figure 5.4.  Variable data precluded conclusions as to the presence or 
absence of an effect for the Work Related Activity subscale.  For the Physical Activity 
subscale there is a trend (solid black line, R2 = 0.3878) for decreasing scores across 
the nine week period of the trial (Phase A,B and C).  This could indicate that the 
decreasing FABQ scores reported by S5 is independent of the intervention, i.e. the 
solid black trendline represents the hypothesis that the interventions of Phase B and C 
do not affect FABQ for S5.  The R2 value of 0.3878 suggests a linear relationship 
between X and Y variables.  A trendline fitted to phase B and C data (dotted grey line, 
R2 = 0.0132) does not have a high enough R2 value to be able to determine whether or 
not an effect occurred.   
 
 
                                                
44 Fear Avoidance Beliefs Questionnaire measures beliefs relating to fear of movement (re)injury in 
chronic pain patients. 
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Figure 5.4: FABQ Scores pertaining to beliefs relating to fear of (re)injury related to movement.  Measurements were 
recorded once weekly during phases A and C and three times weekly during phase B. Vertical lines mark changes in 
phase. R2 value surrounded by solid black box describes fit of solid black trendline to data from phases A ,B and C for the 
Physical Activity subscale.  R2 value surrounded by dotted grey line describes fit of dotted grey trendline to data from 
phases B and C for the Physical Activity subscale.  Phase A is baseline, where no intervention is applied. Phase B is the 
intervention phase, where once weekly clinical treatments sessions occur and home, self-directed intervention is required. 
During phase C clinical treatment is withdrawn but home based self directed intervention remains. 
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S5 Intervention Phase Immediately ‘Before and After’ Treatment 
Visual Analogue Scale (VAS) 
 
Figure 5.5 shows a visual analogue scale for Pain Right Now taken immediately 
before and after clinical treatment with Simple Contact during the three weeks 
intervention period, phase B.  This additional pain rating was recorded in order to 
ascertain whether there was any short term effect of the intervention on Pain Right 
Now levels.  Both ‘before’ and ‘after’ scores are 0 in the first week.  During the 
second and third weeks they occur at 1 for the ‘before’ score and 0 for the ‘after’ 
score, indicating there may be a short term positive effect of the intervention for this 
subject.  Any effect however is not clinically important as it does not reach 15 
percentage points required to fulfil the MCID45. 
 
 
 
Figure 5.5: Intervention Phase ‘Before and After’ Scores pertaining to perceived Pain Right Now recorded immediately 
before and after Simple Contact intervention/treatment 
                                                
45 The Minimum Clinically Important Difference is the minimum level of change of an outcome 
measure that is considered to be clinically relevant 
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S5 Response Compliance 
 
Responses compliance46 scores for subject 5 over the baseline, treatment and follow-
up phases are summarised in Figure 5.6.  One grouped response was recorded.  There 
were 5 late responses, ranging from 1 to 2 days late.  While responses were for the 
most part compliant with scheduled dates, as with previous subjects late responses did 
occur, rendering subsequent entries more prone to error.  Interpretation of data is thus 
less reliable.   
 
Figure 5.6: Measurement Responses; indicating the scheduled (target) day of the trial each set of measurements was to be 
submitted plotted against the actual (recorded) day each response was submitted. Multiple lines converging on 1 recorded 
point (grouped data) indicates multiple days’ worth of measurement data submitted on one day. Inclined lines indicate 
late responses. Declined lines indicate early responses. Steeper slopes indicate a longer time before or after the target date 
responses were submitted. 
 
 
                                                
46 Response Compliance meaning the degree to which subjects submitted measurement data on the 
dates scheduled.  Tardy or early responses indicate a lack of compliance. 
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Chapter 5: Summary of Findings in Individual 
Subjects 
 87 
Summary of Findings in Individual Subjects 
 
In this section, important findings pertaining to individual subjects will be briefly 
summarised.  The discussion initiated in this section will then be further explored in 
Chapter 6. 
 
During the baseline phase, no intervention was applied.  In most cases the small 
number of data points collected during the baseline phase make it difficult to 
confidently identify trends.  The next phase is initiated by the application of the 
intervention Simple Contact by the practitioner.  This intervention is continued in 
once-weekly clinical sessions, and prescribed daily twenty-minute homework sessions 
of ideomotor movements.  Data recorded in the intervention phase is often variable 
making analysis difficult.  However, two subjects recorded less variable data on the 
Tampa Scale for Kinesiophobia (TSK).  This data suggests there was no effect of the 
intervention on kinesiophobia for two out of five subjects (S2 and S5).  The data is 
inconclusive for other subjects.  In contrast, Visual Analogue Scale (VAS) Pain Right 
Now scores recorded immediately before and after clinical treatment sessions with the 
intervention Simple Contact suggests short-term beneficial effects of the intervention 
in three subjects (S1, S2 and S5).  Data recorded regarding compliance with 
scheduled dates for submission of results by subjects identified a general lack of 
compliance, with two subjects (S1 and S3) exhibiting very low compliance.  This 
suggests that all conclusions from this study need to be treated cautiously.  
 
The third phase was the follow-up phase, in which the weekly clinical Simple Contact 
sessions were withdrawn but the patients were encouraged to maintain their daily 
homework sessions of ideomotor movements.  Results in this phase also tended to be 
variable, making it difficult to identify trends or conclude whether or not an effect 
was present.   
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Subject 1 
 
Results for subject 1 were characterised by an inability to infer whether or not there 
was an effect on data recorded in the intervention and follow-up phases due to the 
Simple Contact intervention.  However, a clinically important decrease in pain 
intensity (Pain Right Now) was recorded after intervention.  A decrease was also 
evident in Typical/Average Pain and Pain at Best subscales, although these reductions 
were not of clinically important47 levels.  While it was not possible to confidently 
infer causality of the intervention due to variability of the baseline data, these results 
do suggest the possibility that the intervention could have decreased pain intensity 
levels for subject 1.  Further study is required, perhaps with more data gathered to 
confidently establish the baseline.  Although this does have ethical implications as 
denying treatment for an extended period of time may potentially harm the subject 
(Sim, 1994). 
 
Neck disability scores demonstrated a decrease over all three phases of the trial, and a 
hypothesis that this decrease was not due to the intervention was supported by a 
trendline fitted to data from all three phases.  The result may appear contrary to what 
interpretation based purely upon visual inspection might suggest.  Intervention and 
follow-up data points appeared to be decreasing, perhaps suggesting the intervention 
had a beneficial effect.  However, such a decrease was also apparent in the baseline 
phase, in which no intervention was present.  The rate (or slope of the trendline) at 
which the decrease occurred when the intervention was applied is not apparently 
different to that of the baseline data, suggesting that if no intervention had been 
applied this decrease in score would still have occurred.  Thus it is possible to suggest 
that the intervention had no effect of neck disability levels for subject 1. 
 
Data recorded immediately before and after clinical intervention sessions showed a 
clinically important change in Pain Right Now scores.  This suggests that there may 
be a short term beneficial effect associated with the intervention Simple Contact.  This 
finding may warrant further investigation into potential short-term benefits of the 
intervention, however the result must be viewed with some caution.  The results being 
                                                
47 The Minimum Clinically Important Difference is the minimum level of change of an outcome 
measure that is considered to be clinically relevant 
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recorded immediately prior to and following treatment, the clinician was present in 
the room with the patient, although did not observe the results until termination of the 
intervention phase.  The subject however was in not blinded to their results and results 
recorded following the treatment were not independent of those recorded prior to 
treatment; it is likely that with the short 30 minute duration of treatment that the 
subject would have remembered what the response was prior to intervention.  Further 
it must be noted that the patient may have indicated an improvement due to a wish to 
please the clinician.  It has been documented that outcomes from treatment including 
reported symptomatic improvement may be influenced by patients wishing to appear 
to be ‘good patients’ (Evans, Collins, & Grundy, 2006; Sudak, 2006). 
 
An aspect which may have compromised the integrity of the results is the fact that 
subject 1’s compliance with scheduled dates for submission of outcome measurement 
was particularly poor.  Late submission of all measured outcomes is likely to have 
negatively impacted internal validity of the current work. Also, multiple days-worth 
of measurements submitted as a group will have cause data to be dependent.  As such, 
all results recorded for subject 1 must be interpreted with caution.  Further discussion 
of compliance data is presented in chapter 6 
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Subject 2 
 
While subject 1 appeared to be generally improving subject 2 was not improving and 
on most scores levels appeared to worsen.  Results for subject 2, similar to subject 1, 
were characterised by a general inability to infer whether or not there was an effect on 
due to the intervention Simple Contact.  Limited and variable baseline data points 
render analysis difficult.  Results obtained in three of the measurement categories do 
however warrant discussion; Neck Disability Index (NDI), TSK and VAS recorded 
immediately before and after clinical intervention during the intervention phase. 
 
For the NDI, weak data and poor R2 values of trendlines fitted to all three phases of 
the trial compared with intervention and follow-up phases did not allow conclusions 
as to the presence or absence of an effect due to the intervention.  Visual inspection of 
data may be more interesting.  Whilst the trendline fitted to all three phases weakly 
suggests a possible linear relationship between the x and y variables, visual inspection 
suggests other interpretations are possible.  For instance, the data appears to plateau 
during the follow-up phase.  Analysis of data by application of trendlines attempts to 
model a relationship between x and y variables, and where the fit of data to trendlines 
is good one may assume that the relationship is linear (Steyerberg et al., 2001).  Thus 
in the case of subject 2, the apparent visual trend for a plateau of data and the poor fit 
of the trendline suggest that a relationship of variables other than a linear one may 
exist. 
 
Results obtained for TSK measurement suggest that the intervention did not affect 
apparent rising levels of kinesiophobia.  Visual inspection could suggest a decreasing 
baseline (however, this is based on only three data points).  This is followed by an 
apparent increase over the subsequent phases of the trial indicating the possibility of a 
negative effect of the intervention.  However, a trendline for all three phases shows a 
convincing incline, suggesting that the increase was not due to the intervention and 
that this subject’s kinesiophobia is increasing independently.  A trendline fitted to the 
post-intervention data is not apparently different, further supporting the hypothesis 
that the trend is independent of the intervention.  From visual inspection of this data it 
may be tempting to suggest a detrimental effect. 
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Another point worthy of discussion is data recorded in the VAS measure.  Pain Right 
Now levels immediately prior to and following Simple Contact sessions during the 
intervention phase decreased from levels recorded prior to treatment, and the 
magnitude of decrease was clinically important.  This suggests that the intervention 
was beneficial to subject 2 in the short-term.  However as with subject 1, blinding did 
not occur for this measurement, and interpretation of the result must be with the 
possibility of the subject’s possible wish to please the clinician in mind (Evans, 
Collins & Grundy, 2006; Sudak, 2006).  Interestingly, the subject described changes 
in affect following the weekly contact for treatment, mentioning feelings of elation, 
increase in hopefulness and increase in energy levels.  Unfortunately the current study 
did not include a measure of psychosocial factors.  An instrument such as the “Life 
Orientation Test” developed by Scheier & Carver (1985) which measures 
dispositional optimism would have been useful in the case of patient 2.  
 
Compliance for subject 2 was better than for subject 1.  Generally speaking results 
were submitted when they were scheduled, however some late responses did occur.  
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Subject 3 
 
Results for subject three are particularly variable, and it was not possible to ascertain 
whether or not an effect was present in any of the measurements recorded.  There is 
one set of results that does merit some discussion for subject 3.  Compliance data for 
scheduled submission of responses was notably poor in this subject.  As with subject 
1, there were more instances of late submissions than there were of submission 
occurring on the scheduled date.  This means that the internal validity of data 
recorded for subject one must be considered particularly weak.  Even if one assumes a 
minimal effect of this documented poor compliance upon internal validity, allowing 
estimates accuracy of recall of pain levels being reliable for up to one week (Jantsch 
et al., 2009), the fact that submission twice occurred before the scheduled date must 
cause inaccuracy in results.  Further, multiple responses submitted as a group imply 
dependence of that data, an additional threat to internal validity.  Further discussion 
regarding compliance data is presented in chapter 6. 
 
It may be pertinent to make some comment regarding variability of data for subject 3.  
Week 6 marks her return to work after having been on maternity leave for some time 
(personal communication, subject 3, 13 September 2008).  Prior to this point in the 
trial, subject 3 had completed activities largely comprised of cooking and minding her 
newborn and an older child, and despite leading the very busy life of a mother, she 
described having time to take a break when her pain required.  Thus the period of the 
trial encompassed two major changes which potentially affected her pain: the 
aforementioned return to work and the paradigm shift of responding to her pain with 
movement- as required by the intervention- rather than stasis.  Subject 3’s occupation 
being computer related requires her to be seated for much of her day, likely the 
‘victim’ of those cultural aspects described by Dorko (2003) requiring she repress any 
urges to instinctual movement that might arise.  This return to work may go some way 
to help explain the variable pattern of data recorded following weeks 6, particularly in 
the Quadruple Visual Analogue Scale (QVAS) and Fear Avoidance Beliefs 
Questionnaire (FABQ). 
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Subject 4 
 
Subject 4-recorded data, which precluded the possibility of inferring whether or not 
any change observed, was due to the intervention.  One exception may be in the 
scores recorded for kinesiophobia (TSK measurement instrument).  It was not 
possible to suggest that change occurring in this measurement was due to an effect, 
however visual inspection revealed baseline scores which apparently increased over 
the three week period, while a steady decrease in scores was evident over the 
subsequent 6 weeks.  A trendline fitted to data from intervention and follow-up phases 
had a high R2 value, such that had there been more data points in the baseline phase it 
is tempting to suggest that the decrease in kinesiophobia evident in intervention and 
follow-up phases may have been due to the intervention.  Note however, that while a 
decrease in scores did occur, the actual magnitude of the decrease was negligible. 
 
Compliance with scheduled submission days for subject 4 was also poor further 
compounding an inability to draw conclusions from this data.  While not as poor as 
other subjects enrolled in the study, grouped responses and late submission of data 
were common with this subject.  The internal validity of this data is therefore 
questionable. 
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Subject 5 
 
Recorded data for 5 was similar to that of other subjects enrolled in the study, in that 
it is difficult to conclude whether or not the intervention has an effect.  This was 
largely due to high variability of the limited baseline data causing analysis of data 
from subsequent phases to be difficult.  An exception to this was evident in the TSK 
measure, measuring kinesiophobia. 
 
Kinesiophobia scores demonstrate an apparent decrease over all three phases of the 
trial, and a hypothesis that this decrease was not due to the intervention is supported 
by trendlines fitted to data from all three phases compared with data from the 
intervention and follow-up phases.  The result may appear contrary to what 
interpretation based purely upon visual inspection might suggest.  Intervention and 
follow-up data points appear to be decreasing, perhaps suggesting the intervention had 
a beneficial effect.  However, such a decrease is also apparent in the baseline phase 
before intervention occurred.  The rate (or slope of the trendline) at which the 
decrease occurred when the intervention was applied is not apparently different to that 
of the baseline data, suggesting that this decrease in score was independent of the 
intervention. 
 
Subject 5 also recorded results which suggest a short term effect of the intervention on 
pain intensity levels.  Pain Right Now levels recorded immediately prior to and 
following clinical intervention with Simple Contact during the intervention phase 
show a decrease in level after treatment in the second and third weeks of the phase.  
This decrease was not of sufficient magnitude to be considered clinically important, 
but in the light of similar results occurring for other subjects in the trial it is worth 
considering. 
 
The fact that subject 5 had such low starting scores, particularly in the VAS measure 
described in the previous paragraph may have served to mask an important reduction.  
When a minimum clinically important level must be exceeded, where a starting score 
is low there is not a lot of room for improvement.  In some of the figures plotted, 
follow-up phase data is recorded at lower levels than data in previous phases.  It is 
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possible that low starting values may risk the interpretation the results as being 
unimportant or trivial, when for the subject such changes may represent a significant 
change.  Recall that responses to items of measurement instruments are subjective, 
and that pragmatically a change from a maximum point of 3/10 to a minimum of 0/10, 
whilst small in magnitude, may represent a meaningful change to the individual 
concerned. 
 
It is important to note is the fact that subject 5 commented that she had been able to 
discontinue her use of analgesia during the intervention and follow-up phases of the 
trial (personal communication, subject 5, 1 November 2008). Previously she had been 
using it daily whenever she was working and often when she was not.  Clearly 
without data recording this decrease in use it is not plausible to admit this as 
supporting effectiveness of the intervention.   In future studies it would be useful to 
also collect data on medication use. 
 
Compliance for subject 5 was better than either subjects 1 or 3, with most submissions 
occurring when scheduled.  However some late responses were recorded. 
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Chapter 6: General Discussion 
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General Discussion 
 
This section of the document will discuss results obtained in the current study, 
highlighting difficulties with interpretation of data such as variability and limited 
baseline points.  Methods used to interpret data will also be discussed.  The single 
system research design will be explored, and aspects of its design relating to the 
current work and more generally will be outlined.  Findings of the present work 
regarding subjects’ lack of compliance with submission of self-report measures will 
be discussed as a potential methodological weakness of the single system design. A 
section will be presented discussing measurement of change in studies such as the 
current work, before comparisons are made between the current study and similar 
research.  After areas for future improvement are outlined, a final section will make 
concluding statements. 
 
Analysis of data 
 
To facilitate visual inspection of data plots, trendlines (also termed linear regression 
lines) were fitted to data plots where visual inspection suggested a possible change 
occurring subsequent to the baseline phase (Bithell, 1994).  Where such a change was 
observed, two trendlines were fitted.  One was fitted to data from all three phases, and 
a second to data in the intervention and follow-up phases.  This allowed comparison 
of slopes, where a change in slope for the trendline fitted to intervention and follow-
up phases indicated a possible positive or negative effect of the intervention. 
 
In general, because of poor fit of trendlines to data, it was not possible to confidently 
determine whether an effect was present.  However the TSK measure in subjects 2 
and 5 had a fit sufficient to allow some conclusions to be drawn.  In these two cases 
the conclusion is that the intervention had no effect.  R2 values for these two plots 
were of sufficient magnitude to suggest simple linear relationship between x and y 
variables (Steyerberg et al., 2001), and represented a hypothesis that the interventions 
of the intervention and follow-up phases did not effect TSK scores for the particular 
subjects.  A trendline fitted to data from the intervention and follow-up phases did not 
display sufficient difference in slope to suggest the intervention had an effect on 
changing scores; that is, the intervention had no effect.  In cases where low R2 values 
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occurred the poor fit of trendlines precluded comparison of change in slopes between 
trendlines fitted to all three phases and to data from intervention and follow-up 
phases, and suggested that the relationship between x and y variables is not accurately 
described by a linear equation. 
 
Several factors were present that detracted from the accuracy of trendlines fitted to the 
data obtained in this trial.  It has been stated that at least seven data points are 
necessary in the baseline phase in order to accurately identify trends occurring in this 
phase (Bithell, 1994).  There should also be an equal number of points in subsequent 
phases (Bithell, 1994).  This was only the case for the QVAS and PSFS measures.  
This lack is detrimental to the robustness of data and its subsequent analysis, as it not 
possible to achieve stability in baseline data or to ascertain whether there is a clear 
trend (Bithell, 1994).  The decision to decrease measurement frequency was made 
after consideration of the possibility of serial dependency. 
 
Serial dependency occurs where data points are closely related- in this case occurring 
within close temporal proximity- they become predictive of one another; successive 
observations occurring in series tend to be strongly related (Bithell, 1994).  Serial 
dependency also has wider implications for the selection of statistical tests for 
analysis of data in this study.  The issue of serial dependency was one reason to 
increase measurement intervals and thus decrease data points collected. 
 
Inferential errors such as Type I, where the experimental hypothesis is supported 
when false, and Type II – where the hypothesis is rejected as false when it is in fact 
true are common errors when analysing results in single system designs, as is also true 
for other, more robust, methodological designs including controlled trials (Evans, 
2003; Bithell, 1994).  A central assumption in the use of inferential statistical tests is 
that data groups are independent (Backman & Harris, 1999).  Given the likelihood of 
serial dependency occurring in single subject designs such as the present study, such 
an assumption of independence is not plausible, and indeed the requirement for serial 
independence cannot be met in SSRDs.  Were analysis such as inferential statistics to 
be applied to data that is dependent, results would tend to overestimate the 
significance of any differences observed between phase data in the trial (Bithell, 
1994).  Furthermore, the use of parametric tests such as the t-test requires data be 
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normally distributed (Sanders, 2003).  It is unlikely that small data groups such as is 
common with single system designs are normally distributed.  Increasing the number 
of data points would go some way to resolving this issue, however, the implication for 
the single system design is extending the trial period, including the baseline period, or 
increasing the number of observations.  Not only would increasing the number of data 
points increase the likelihood of serial dependence occurring, there are also ethical 
considerations in doing so.  By withholding treatment for a longer period of time, any 
undesirable or detrimental effects due to lack of treatment may become more 
pronounced.  Patient welfare and wellbeing must be of paramount concern, and it 
would be unethical to expose a patient to pain or discomfort they might not have 
suffered had they not been part of a study (Sim, 1994). 
 
Without the benefit of the use of the statistical tests mentioned above and where low 
R2 values are recorded, visual inspection of data trends has been advocated as a viable 
method of analysis (Backman & Harris, 1999).  Research indicates that visual 
inspection of data may provide similar inferences as statistical methods of analysis 
were they applicable (Bobrovitz & Ottenbacher, 1998).  Unfortunately there are also 
drawbacks to relying on visual inspection to interpret results. For example, in a study 
of single system design, Kazdin describes a potential for effective treatments to be 
discarded prematurely where apparent visual impact is poor (Kadzin, 1982). 
 
It is evident that there are inherent difficulties with statistically analysing single 
system data.  There is an overall reliance upon visual analysis of results and given the 
variability of data recorded in this trial such visual analysis can be difficult.  For this 
reason, 95% confidence intervals were calculated for baseline phase data of some 
plots as an aid in clarification as to whether a treatment effect was present.  In the 
context of the current study, application of confidence intervals did, in some cases, 
indicate some effect, however, with variable or limited baseline phase data it was in 
some cases not possible to assume that these points occurring outside the confidence 
interval for the baseline phase were due to the intervention or an extraneous factor.  
Such extraneous factors may have been events such as S3’s return to work after 
maternity leave. 
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Single system methodology 
 
The single system design was selected for the current research for two main reasons: 
i) the emergent nature of the topic, and ii) the utility of the design within a pragmatic, 
clinical setting.  Within the hierarchy of research designs, the SSRD features towards 
the low end (Evans 2003) and is a method appropriate for developing a foundation of 
evidence for an emergent topic (Moran, 2005).  Within manual therapy, the 
application of ideomotion and Simple Contact is an emergent therapeutic approach.  
Very little published literature exists regarding effectiveness of ideomotion as a 
treatment for acute or chronic pain.  The SSRD is also a useful design by virtue of its 
being a pragmatic approach to research, with results immediately useful in a clinical 
context; results obtained from a single system design more closely resemble typical 
clinical experience compared to explanatory controlled trials.  
Suitability of SSRD subtype 
 
The application of phases varies within SSRD studies.  This work employed an A-B-
C design, where phase A is a baseline phase, B intervention, and C follow-up phase.  
Due to the requirement of continued practise of ideomotion by each subject up until 
the end of the study, alternative variations such as an A-B-A design, where the final 
phase is a return to conditions experienced within the baseline phase, was deemed 
inappropriate.  Neither did the current study employ a multiple baseline method. 
 
The multiple baseline method staggers the length of the baseline period so that each 
subject commences the intervention stage of the study at a different time.  This 
method is intended to control threats to internal validity, such as environmental 
factors and the possibility of spontaneous recovery – maturation bias – such that it is 
possible to cautiously infer causality (Domholdt, 2005; Keating et al., 1985).  Given 
the inclusion criteria required that subjects in the study reported neck pain duration of 
6 months or longer, it was considered to be unlikely that maturation bias would be an 
issue which would impact upon the validity of results.  Environmental aspects 
effecting symptoms were likewise considered to be of minimal threat.  This said, 
when interpreting results it is important to consider the possibility that internal 
validity may have been affected by the factors aforementioned.   
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External validity 
 
The extent to which results obtained in a single system design are generalisable to 
wider populations is the subject of debate (Sim, 1994).  Standing on its own, this 
work is not sufficient to be able to generalise results outside of the small population 
studied.  A novel idea to overcome this intrinsic weakness of the SSRD has been 
proposed by Ottenbacher & Hinderer (2001).  By aggregating SSRD experiments 
investigating a similar question and synthesising results a more substantive body of 
clinical knowledge may be pooled.  This form of meta-analysis would be a useful way 
of overcoming issues of limited generalisability.  Such a method could usefully be 
applied to the current work; at the time of writing, one other unpublished SSRD series 
investigating the effects of ideomotor therapy on chronic neck pain exists (Rickards & 
Lucas, 2009). 
 
The low number of data points, particularly in the baseline period has been raised 
previously as an issue commonly experienced in single system design research.  Data 
recorded in the study is particularly prone to error due to this failure of the work to 
employ a baseline period of sufficient duration to attain stability (reasons for this are 
discussed later).  With few exceptions, plots of recorded data show a volatile baseline 
period, and the absence of a stable baseline makes it difficult to conclude causal 
relationships between outcomes and intervention (Bithell, 1994).  By extending the 
baseline period more data points could be obtained, increasing the resolution of 
results.  In addition to the problem of increasing serial dependence, there is also a 
logistical difficulty with such a solution.  By extending the baseline period the 
duration of time for which treatment is withheld becomes longer.  The ethical issues 
of withholding treatment have been mentioned in previous sections.  Further to these 
issues is the degree to which a trial such as the current work impacts on the life of the 
subjects under study.  This study was of 9 weeks, and in the case of one subject, 10 
weeks duration.  Nine weeks of commitment to a research project is a major 
undertaking for participants.  Several undesirable effects including increased subject 
dropouts and general ambivalence towards accuracy of reporting on measures and 
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increased difficulty in recruitment of subjects may be resultant from extending the 
period of the study 
 
A further consideration in adding further data points is the timing and intensity of 
measurement.  The study employed five measurement instruments with varying 
frequency of completion for each.  In the interests of regular collection of results and 
fulfilling the minimum period to which each instrument is sensitive to change it was 
decided that there would be three weekly returns of measurements occurring 48 hours 
apart (with the exception of one interval by necessity being longer at 72 hours due 
wishing to maintain the same days of measurement each week).  During the 
intervention period all five instruments were employed for each scheduled response 
period.  Requiring this degree of commitment for 9 weeks was considered to be too 
onerous for subjects, an opinion shared by the Unitec Research Ethics Committee 
(UREC) during the ethical review process.  This consideration necessitated a 
reduction in the frequency to which some measures were reported.  This reduction 
further decreased the number of data points available for the baseline and follow-up 
phases of the trial.  Thus the difficulty in obtaining enough measurement points to 
provide a stable baseline was clearly present in this work, and presented challenges in 
interpretation of results.  
 
In spite of the intrinsic difficulties associated with increasing the time period of the 
trial, it is clear that it would be useful to increase the baseline and follow-up periods.  
The raw data in the current study are not easily interpreted, and generally it was not 
possible to attribute observed change as being due to the intervention.  Interpretation 
of results in the current study was compromised by the inability to determine trends in 
baseline data to compare to intervention data.  Increased numbers of data points 
would have rendered more results easier to interpret, provided the nature of the 
relationship between x and y variables were represented by a linear equation. 
Similarly, were the trial to continue longer by increasing the length of the follow-up 
period, results more similar in nature to those obtained in a clinical setting- where the 
duration of treatment is not limited by a pre-agreed timeframe- may have been 
obtained.  Such an improvement would of course be reliant on the subject maintaining 
their practise of the intervention and its being performed correctly and effectively, an 
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assumption which is problematic given the degree of non-compliance to clinical 
advice common in patients (Kravitz et al., 1993)  
 
Given the frequency with which trendlines poorly fitted data it is not appropriate to 
extrapolate observed rates of change to predict future levels.  Extrapolation of 
baseline trends may be a useful way of generating context with which to examine the 
possibility of a treatment effect in intervention and follow-up phases.  The difficulty 
with such an extrapolation is that it would likely be prone to error.  Not only is this 
due to the poor fit of trendlines previously mentioned, but it also assumes that trends 
observed will be linear.  For example, if the baseline trend of disability and pain 
levels was increasing, linear extrapolation would predict that eventually disability 
would become total and pain would reach the worst level possible.  This is not likely, 
particularly in cases of chronic pain where pain and disability levels have tended to 
remain constant.  For this reason baseline extrapolation was not employed in the 
current study.  
 
A further important point must be raised regarding the use of trendlines for data 
analysis.  The use of linear regression trendlines as aids to analysis of data clearly 
assumes that change in measured variables, whether due to the intervention or not, 
will progress in linear fashion.  The current work also attempted interpretation of data 
based on this assumption of linear change.  Some results obtained in the current study 
indicate that change in measured variables may not be linear in function (e.g., figure 
2.1) and as such, linear analysis may have underestimated any effects of intervention 
present. 
 
Accuracy of scheduled reporting 
 
Single system design studies rely upon the goodwill of the subjects to respond 
honestly and accurately to measures selected for the particular subject of interest.  
SSRDs typically employ patient self-report measures using paper forms for 
measurement, assuming that responses acquired from subjects have been penned on a 
selected date and preferably at a similar time of day for each response.  When 
analysing and interpreting results, the assumption is made that the data collected 
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occurred on the scheduled date, and conclusions are made accordingly.  The use of 
electronic data collection methods in this study allowed for an evaluation of subject 
adherence to the measurement schedule.  Evaluation of the adherence data indicates 
the assumption that subjects respond when they are scheduled to is often flawed. 
 
In an effort to simplify recording and help blind subjects to their previous results, an 
online collection system was used for subjects to record and submit their responses 
for each outcome measure.  Upon submission of the results, a time and date stamp 
was added by the electronic survey system making it possible to know exactly when 
the response was received.  Many responses were submitted on the scheduled date, 
however, it is apparent that measures were frequently submitted after the scheduled 
time.  Not only did submissions occur late, in two cases results were recorded before 
the scheduled date (figure 3.6).  It is not possible to know whether such extremes in 
reporting times were due to subjects misunderstanding their schedules or simply 
making mistakes, or whether the onerous nature of frequent recording caused apathy 
in subjects which precluded accurate measurement.  It is also possible, but less likely, 
that such delays came about due to errors with the electronic database used, or 
personal computer technical errors.  It was no surprise to encounter submission delays 
of 1, 2 or even 3 days, time periods which while less than ideal, it is still conceivable 
that subjects may recall their relative ratings for that day.  With delays occurring over 
three days late it becomes increasingly unlikely that recorded results are 
representative of the levels experienced.  Obviously results obtained before the 
scheduled date cannot be considered representative of actual levels on scheduled 
recording days. 
 
Conditioning studies demonstrate that memory of a painful stimulus persists for up to 
one month in animals, demonstrated by avoidance behaviour occurring even when the 
painful stimulus had been withdrawn (Hummel, Lu, Cummons, & Whiteside, 2008).  
Such findings illustrate the potential for a persistent memory of pain up to a month 
after it is experienced.  There is a small body of literature regarding the accuracy of 
recall for pain ratings and what time periods may be involved before memory of 
actual pain levels becomes unreliable.  Linton & Gotestam (1983) reported that when 
patients were asked to recall previous episodes of pain they significantly overestimate 
the level of pain which occurred.  It has also been suggested that present pain levels 
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experienced by patients may influence the memory of previous episodes of pain 
(Eich, Reeves, Jaeger, & Graff-Radford, 1985)  A more recent study of 
experimentally induced pain found that accurate memory of pain levels persisted for a 
week after the painful stimulus (Jantsch et al., 2009).  Psychological research into 
short-term recall contends that time delay does not affect recall ability, but that 
interference during acquisition of memory items and interference during recall of 
memory affects the accuracy of items recalled (e.g., Lewandowsky, Duncan, & 
Brown, 2004; Oberauer & Lewandowsky, 2008; Portrat, Barrouillet, & Camos, 2008)  
Three points, delay duration (the time past acquisition of memory), the effect of 
present pain on pain memory, and interference emerge for discussion in reference to 
this evidence.  Regarding delay, it appears possible that the integrity of pain memory 
retains its fidelity for up to a week (Jantsch et al., 2009).  However, the effect of 
longer durations on recall of pain, such as recorded in the current work, may be more 
likely to cause erroneous estimation by subjects, such as reported by Linton & 
Gotestam (1983).  The current study recorded delays in response of up to three times 
that studied by Jantusch et al., (2009) and both anecdotal and personal experience 
would suggest that the clarity of recollection diminishes the further one gets from the 
date of the painful event.  Thus it does not appear likely that long delays in 
responding would be lead to accurate recollection of pain ratings.  Further, most of the 
instruments used measured variables other than pain, such as disability or functional 
status. There does not appear to be any literature relating to recall of functional status, 
but one would contend that it seems even less likely to be memorable than pain.  Also, 
the level of pain experienced by subjects at the time of recording measurements may 
have caused them to overestimate the past intensity of pain.  As such, Pain Right Now 
levels recorded retrospectively may have been magnified.  Interference may have 
affected recall; everyday events such as telephones ringing, children requiring 
attention, housemates, emails arriving in the inbox- particularly relevant due to the 
method of the current study requiring computer use when submitting measurements- 
to name but a few, are very likely to have been a distraction to subjects while they 
were engaged in filling out measurement forms, further decreasing integrity of results 
submitted. 
 
These findings regarding the extent to which reporting of measures lacked accuracy is 
a clear weakness of the present study.  Furthermore, the findings may illustrate an 
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important methodological weakness of the single systems study reliant on self-report 
measures using methods that may be edited/altered at times other than those 
scheduled.  Not only are results less likely to be accurate due to late (or even early) 
recording, but multiple days’ results recorded concurrently – another factor observed 
in the current work – clearly lack independence. 
 
Interestingly, a review of studies investigating the use of electronic devices in the 
collection of data from research subjects suggests that despite potential drawbacks 
associated with technical malfunction, results were generally of superior quality when 
collected digitally (Lane, Heddle, Arnold, & Walker, 2006)  Lane, Heddle, Arnold & 
Walker (2006) also contend that patient compliance to instructions regarding 
recording and submission of data was superior when electronic devices were used 
(Lane, Heddle, Arnold, & Walker, 2006).  Thus the potential for error with self report 
measures seems increased in studies where electronic submission was not used, 
particularly given the error encountered with compliance to submission in the current 
study. 
 
Additional tools for outcome measurement 
 
Another weakness of the current study was the absence of a medication diary.  Whilst 
only three of the five subjects included in the trial used medication to control pain, it 
would have been useful to record the daily intake of those who did as an additional 
measure of change.  Subject 5 verbally reported being able to discontinue her use of 
analgesia by the end of her trial.  This highlights the fact that the current study cannot 
know the impact of medication usage on the results obtained from subjects. 
 
The extent to which patients comply to advice offered by clinicians regarding home 
exercise is well documented (e.g., Christensen, 2000; Milroy & Oneil, 2000) and 
barriers to compliance and methods of increasing adherence are also well studied 
(e.g., Lew, 2001; Merritt, 2001; Milroy & Oneil, 2000)  The current study required 
independent sessions of ideomotion to be completed daily by subjects, and it is likely 
that varying levels of compliance occurred.  The level of compliance is likely to 
influence the rate of change experienced, where more frequent practise is likely to be 
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more beneficial than irregular practise.  A daily practise diary was excluded in the 
design of the study because it was considered that subjects already had a high load of 
measures to complete.  Having accurate data as to the amount of time spent by each 
subject completing ideomotor movements would have been very useful alongside data 
of rates of change. 
 
Blinding and application of the intervention 
 
One final weakness to the present work must be documented.  Due to logistical 
difficulty, the practitioner administering Simple Contact during the intervention phase 
was also the study investigator.  This biases the results of the study due to decreased 
objectivity.  Further, Pain Right Now VAS scores collected immediately before and 
after clinical sessions of Simple Contact were done in the presence of the investigator.  
Neither subjects nor the author were blinded to the score obtained prior to treatment 
during recording of the score following treatment.  It is also possible that relative 
inexperience in the use of Simple Contact by the practitioner decreased rates of 
response of subjects to ideomotor movements. 
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Measurement of change 
 
This study set out to investigate the effects of ideomotor movements on neck pain, 
with a view to reduction in pain levels and improving quality of life.  In order to 
assess whether the intervention had any effect, it is necessary to attempt to measure 
and quantify change.  In a clinical setting, ‘meaningful change’ could mean a variety 
of things, from pain levels to functional ability, freedom and range of movement.  
These same definitions of ‘meaningful change’ apply in a research setting.  Beaton 
(2000) highlights that in terms of outcomes within manual medicine, the most 
relevant impact of treatment is in symptom relief, quality of life and functional status.  
It is with this in mind that the five measurement tools were chosen. 
 
Having decided which measurement tools are most appropriate to answer the clinical 
(or in this case research) question, the next question to be answered is what will be the 
most meaningful method of interpreting the results recorded.  While the use of 
inferential statistics is a common way of interpreting data in quantitative clinical 
research, this approach may lack utility in describing clinical relevance of observed 
changes (Beaton, 2000).  In clinical terms, a small but ‘statistically significant’ 
change may not be important to patients and practitioners, rather, interpretation of 
results in terms of ‘meaningful’ change is more helpful.  
 
A more useful way of evaluating change is to utilise quantified levels of ‘clinically 
important change’ – where change not only occurs but occurs to a degree which is 
meaningful to patients, practitioners or third party payers (Beaton, 2000).  
Measurement instruments with well established reliability and validity such as the 
NDI (Vernon, 2008) commonly have an associated level of important change, known 
as the ‘minimum clinically important difference’ (MCID).  For example, the MCID 
for mechanical neck pain measured by the NDI is 19 percentage points (Cleland, 
Childs, & Whitman, 2008).  It is important to realise that this MCID applies only to a 
particular condition being measured – in the case of the current work, mechanical 
neck pain.  For example, the MCID associated with the NDI in cases of cervical 
radiculopathy has been calculated to be seven percentage points (Cleland, Fritz, 
Whitman, & Palmer, 2006).  Thus conclusions as to whether changes in neck pain 
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were clinically important as recorded by the NDI in the current study apply only to 
mechanical neck pain, and not other associated factors, such as freedom of neck 
movement, for example. 
 
It is also important to mention another point discussed by Beaton (2000) related to 
clinically important change; the fact that change must be anchored to a real life 
‘marker’, termed the ‘construct of change’.  Beaton (2000) cites Riddle et al (1998) as 
selecting attainment of treatment goals as being a useful marker of change for their 
study.  Thus the amount of change that is considered important is not only related to a 
specific type or aspect of dysfunction, but is also rooted in a specific context of 
change.  We can therefore make no firm conclusions, even with a measure of 
clinically important change, as to whether meaningful change for the patient has 
occurred on a level that is important to them.  With this in mind, whilst results 
indicate that with obvious notable exceptions changes recorded were not clinically 
important, they may still have been of sufficient magnitude to be meaningful on levels 
not accounted for by the measurement tools used. 
 
A final point illustrated by Beaton (2000) is relevant for discussion here.  Some 
subjects enrolled in this study exhibited baseline levels as being relatively low.  
Riddle et al., (1998, cited in Beaton 2000) discovered that meaningful cut-off points 
of important change would vary depending on the level their subjects reported during 
baseline phases.  If the subject reported less disability, they concluded a smaller 
amount of change would be an important threshold, where subjects with higher 
baseline scores required a higher level of change to be considered important.  For 
instance, subject 5 had decreasing mean levels on the NDI measurement from the 
baseline to follow-up phase of the trial.  These decreases did not satisfy the MCID of 
19 percentage points, however, scores during baseline and throughout the study were 
relatively low.  Perhaps in the case of subject 5 an MCID of 19 percentage points is 
too large, and a conclusion that no important change occurred should be considered 
cautiously.   
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Comparisons with similar research 
 
At the time of writing, only one published study investigating the concept of 
ideomotor therapy used for the treatment of mechanical pain exists.  The author is 
aware of a second SSRD series currently in the process of being edited for publishing 
(personal communication, L Rickards, 17 January 2008).   
 
Table 8 summarises key points of comparison between the three pieces of work.  Key 
differences between the current study and those of McCarthy, Rickards & Lucas 
(2007) and Rickards & Lucas (2009) are evident firstly in the choice of outcome 
measures.  Both studies employed a depression anxiety and positive outlook scale 
(DAPOS), while the study by Rickards & Lucas (2009) also measured the level of 
disability due to low back pain, and as such employed the revised Oswestry pain 
questionnaire.  The study by Rickards & Lucas (2009) was also of longer duration, 
and employed a multiple baseline design.  Notably, McCarthy et al, (2007) also 
elected to provide their subject with basic education regarding pain neurophysiology.  
Such education was not employed in either the current study or that of Rickards & 
Lucas (2009). 
 
Having completed the study, it is clear that a measure of psycho-emotional change 
would have been useful in this work.  Pincus, Burton, Vogel & Field (2002) 
conducted a systematic review examining the role of psychological factors within 
chronic pain, suggesting that they are an important predictor of chronicity.  Comments 
by subject 2 (discussed earlier) regarding changes in affect may have been present in 
other subjects, and data regarding such change would have been valuable.  Given 
clinically important changes recorded on the DAPOS measure by Rickards & Lucas 
(2009), the addition of a measure for mood state would have been useful in the current 
study. 
 
Both other studies were also able to conclude a positive relationship between the 
introduction of ideomotion-based therapy and a change in scores measured.  
However, Rickards & Lucas (2009) report that one of the four subjects studied in their 
series did not respond as positively as the other three, and discussed the possibility of 
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the existence responders and non-responders to ideomotor-based therapy.  It is 
possible that subjects who demonstrated a beneficial effect could be placebo 
responders.  Consideration of placebo effects would require comparing Simple 
Contact with a placebo intervention in a clinical trial.  It must be noted that the 
inclusion by McCarthy et al., (2007) of subject education in pain neurophysiology 
upon intake may well have had an effect on results obtained in that study.  As 
McCarthy et al., (2007) point out, such education has been shown to alter cognition 
associated with pain, and may also have an immediate effect, increasing physical 
performance (Moseley, 2004; Moseley, Nicholas, & Hodges, 2004).  The exclusion of 
such an influencing factor by this study and that of Rickards & Lucas (2009) will 
likely have aided in identifying effects due to the intervention. 
 
The data collected during the baseline phase of the study by Rickards & Lucas (2009) 
was limited to four points, collected once weekly.  Whilst this decreases the 
likelihood of serial dependency it is important to consider that, similar to the current 
study, insufficient baseline data does not allow the establishment of baseline trend, 
and thus conclusions of beneficial effect in subsequent phases due to the intervention 
are rendered less robust.  Data recorded by Rickards & Lucas (2009) demonstrates 
less variability than the current study however, and visual inspection of data trends in 
intervention and follow-up phases does suggest a beneficial effect of the intervention. 
 
A further possibility which could potentially explain the fact that the current study did 
not completely emulate the results of previous studies is the possibility that 
ideomotion did not emerge in all subjects studied in this research.  As with the studies 
by Rickards (2009) and McCarthy et al., (2007), subjects involved in the current study 
reported surprise at the emergence of movements they considered to have been non-
volitional.  Such feelings of disassociation from movement have been described as 
common characteristics of ideomotor movements (Spitz, 1997; Hyman, 1999).  If this 
experience is indeed confirmation of the presence of ideomotor behaviour, then it 
appears likely that ideomotor movements did occur.   
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Table 8: Comparison of  Studies of Ideomotion 
 Current study Rickards & Lucas (2009) 
McCarthy et al.,  
(2007) 
Design SSRD series, A-B-C SSRD Series, A-B-C multiple baseline SSRD, A-B-C 
Duration 9 weeks 11-12 weeks 9 weeks 
Outcome measures QVAS, NDI, FABQ, TSK, PSFS 
DAPOS*, PSFS, NDI, QVAS, 
ROM** ROPQ*** 
DAPOS*, NDI, QVAS, 
FABQ, PSFS 
Subjects educated with 
basic pain 
neurophysiology 
No No Yes 
Findings 
Few clinically important 
changes, reductions 
observed not clearly 
attributable to intervention 
Positive clinically important 
changes in function, disability, 
active range and mood 
Positive clinically 
important changes in 
disability and function 
Notes 
*Depression Anxiety and Positive Outlook Scale 
**Ranges of Motion (Cervical Spine) 
***Revised Oswestry Pain Questionnaire 
 
 
Areas for improvement in future studies 
 
Previous sections have highlighted several weaknesses of this study.  Two basic 
faults, ones easily rectified, were the absence of measures for medication use, and 
home practice.  As discussed, data regarding medication intake would be a useful 
concurrent measure of improvement, and knowledge as to how much time was spent 
practising ideomotor movements, assuming diary records were accurate, would help 
contextualise change in scores recorded in outcome measures.  Future work should 
include both these diaries.  An area of difficulty experienced in conducting this 
research has been in balancing the need to collect useful data without overloading 
subjects.  From the perspective of the researcher, more information is better, but this 
may detract from accuracy of recorded data and result in subjects dropping out.  
Careful attention must be paid to selection of outcome measures.  For example, the 
current work utilised two measures of fear avoidance.  Perhaps one of these could be 
discarded in future work in favour of an affective measure such as DAPOS used by 
other studies reviewed, or a measure of dispositional optimism such as the “Life 
Orientation Test” (Scheier & Carver, 1985). 
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Methodological weaknesses have also been discussed.  Collecting enough data to 
facilitate accurate analysis but without introducing serial dependence and denying 
treatment for extended periods of time has proved a difficult trade-off.  One way to 
work around this may be to limit measurement during the intervention and follow-up 
phases to once or perhaps twice weekly whilst measuring three times weekly during 
baseline.  Regarding the length of each period, unpublished work by Rickards & 
Lucas (2009) had a time period of 11-12 weeks total.  Care should be taken to avoid 
creating ethical issues by denying treatment for an extended period of time during 
baseline, however, an additional week may not be excessive in light of the long term 
presence of the complaint, and would certainly render data over this period more 
robust.  Extending the length of the follow-up period would be less ethically 
challenging, and whilst perhaps not as useful as extending the baseline period in terms 
of validity of inferences, would provide important information regarding recovery 
rates.  Decreasing frequency of measurement during the follow-up period would limit 
the burden of measurement for subjects. 
 
A major methodological weakness encountered by this work was the lack of 
compliance by subjects with scheduled dates for submission of results, even though 
they were sent email reminders by the researcher.  Such inaccuracy in reporting on 
scheduled dates may decrease the accuracy of the data recorded and threaten the 
internal validity of the study.  Future work must find ways to maximise accuracy in 
order to achieve acceptable internal validity.  
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Conclusions 
 
The aim of this study was to examine the effectiveness of utilising ideomotor 
movements in subjects with chronic neck pain with a view to reduction of symptoms 
and increasing quality of life. Limited baseline data rendered data recorded in 
subsequent phases difficult to interpret, and in general it was not possible to attribute 
any changes observed as being due to the intervention.  R2 values of sufficient 
magnitude to suggests a linear relationship between x and y variables represented an 
hypothesis that the manipulated variable of the intervention and follow-up phases did 
not affect levels experienced by the subjects.  Trendlines fitted to intervention and 
follow-up phase data did not demonstrate sufficient R2 values to confidently support a 
conclusion that the intervention had a beneficial or detrimental effect on measured 
variables.  In two instances trendlines fitted to intervention and follow-up data had 
good R2 values, however the difference in slope between the two trendlines was 
minor, suggesting the intervention did not affect the variable (kinesiophobia) 
measured.  Data recording Pain Right Now intensity levels immediately prior to and 
following clinical intervention sessions during the intervention phase suggests a 
potential short-term beneficial effect of Simple Contact on pain intensity. 
 
The results of this study do not replicate work undertaken by McCarthy et al., (2007) 
and Rickards & Lucas (2009), who were able to conclude that clinically important 
changes were brought about by the expression of ideomotor movements in subjects 
with chronic neck pain.  It should be noted that whilst changes represented in their 
research suggest a decrease in levels of pain and disability and increases in functional 
status, baseline phase data is limited to a maximum of four points.  As such the 
possibility exists that their conclusions have over-estimated the magnitude of change 
in levels due to the effect of the intervention.  If such an overestimation has occurred 
it may be due to the failure to establish sufficient pre-intervention trends. 
 
Perhaps the most important finding of this work relates to the accuracy of reporting by 
subjects, with measures being submitted in a range from -4 to +21 days around the 
scheduled reporting dates.  These findings highlight a methodological weakness, not 
only for this study, but all previous SSRDs that used subject self-reported measures.  
Whilst the single system design is a good model for this type of research, the error 
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associated in tardy (or early) recording of responses may compromise the integrity of 
the data obtained. 
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Appendix 1: Subject Information Sheet 
 
 
The use of ideomotor therapy in the treatment of chronic 
neck pain: A single systems research design 
 
Information Sheet 
You are invited to take part in a research project being undertaken as a part of the 
Masters of Osteopathy Degree.  The research involves investigating the effect of a 
novel manual therapy approach for chronic pain.  This information sheet is designed 
to provide information regarding the nature of the research, and what will happen 
should you decide to participate.  We currently need people who have suffered from 
neck pain for six months or longer and who are aged between 18 to 60 years. 
Unfortunately, if your neck pain is known to be due to diagnosed disc damage or is 
due to diseases such as cancer, obvious medical conditions, ongoing tissue damage,  
inflammatory conditions or nerve-root involvement you cannot be included. 
 
The Researchers 
The researcher is Jesse Mason, with supervision from Dr Craig Hilton and Robert 
Moran.  
 
What will participation involve? 
 
• Attending a brief initial appointment to ensure that you are eligible for this 
project.   
• Discussing the procedures, and being informed of what happens in the 
research.  After you have had time to consider participating you will be invited 
to sign the consent form. 
• Being available for nine weeks during the trial, involving one thirty minute 
contact session per week for three weeks at the Unitec Osteopathic Student 
Clinic. The study process will last for 9 weeks and is fairly simple. For the first 
3 weeks your only commitment will be to fill in a few questionnaires regarding 
your pain levels and function. These forms will be filled out about once per 
week for the duration of the study. The next 3 weeks you will receive 
treatment lasting for 30 mins once per week and will be asked to do some 
home management practice for approximately 20-30 mins per day. In the 
remaining 3 weeks you be asked to maintain your home management 
practice and will need to continue to fill out the forms as in the weeks prior. 
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What is the nature of the intervention and outcome measure?  
 
- The developer of this approach calls the technique Simple Contact because it 
involves only a very light manual contact of the skin by the therapist in an 
effort to make people aware of and fully express their own ongoing instinctive 
movement responses to painful sensation. The technique has been found 
very effective by therapists all over the world, however only limited research 
on the approach has been done yet. 
 
- The outcome measures will be not only your relative pain levels, but also how 
limited you feel you are in completing common day to day activity, with some 
of these- the ones you find most difficult to do because of your pain- 
nominated by you. In addition we are interested in your thoughts and beliefs 
about how your pain affects the way in which your body moves. 
 
 
Potential Risks to Research Participants 
There are no known published data that suggests any risk associated with this 
research. However, the researcher accepts that it is possible that there may be some 
undetermined risks involved in the research process.  In the case that any potential 
risk or harm is identified, for any of the research participants, it will be treated on an 
individual basis.  In any such case the research process will be halted immediately. 
 
Confidentiality 
Confidentiality and your anonymity will be protected in the following ways: 
• All consent forms and completed questionnaires will be seen only by the 
researchers.   
• All hard copies and information will be stored in a locked file in a secured 
room.  Only the researchers will have access to this file.   
• Only anonymous data will be presented in reports related to this research.   
• Electronic files will be protected with an electronic password. 
 
You have the right not to participate, or to withdraw from this research project 
within two weeks of your final data collection.  This can be done by contacting 
Jesse Mason or Dr Craig Hilton by telephone or email, or by verbally informing 
either of them upon contact that you no longer wish to participate. 
 
A final report containing the information from this study will be available at the 
Unitec Main Library upon completion. 
Information and Concerns 
For further information or concerns please contact the researchers by phone or email. 
Jesse Mason 
School of Health and Community Studies 
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Unitec New Zealand 
Telephone: (09) 846 5453 
Mobile: 021 771 715 
Email: mrjessemason@gmail.com 
Or 
Dr Craig Hilton 
School of Health and Community Studies 
Unitec New Zealand 
Telephone: (09) 815 4321   Ext 8601 
Email: chilton@unitec.ac.nz 
 
 
 
 
 
 
 127 
Appendix 2: Subject Consent Form 
 
 
 
The use of ideomotor therapy in the treatment of chronic 
neck pain: A single systems research design. 
 
 
Consent Form 
 
This research is being undertaken by Jesse Mason from Unitec New Zealand, with 
supervision from Dr Craig Hilton and Robert Moran. 
 
Name of Participant:…………………………………………………………………. 
 
I have seen the Information Sheet for people taking part in the research project that is 
investigating the effect of Simple Contact on chronic neck pain. I have had the opportunity to 
read the contents of the information sheet and to discuss the project with the project team, 
and I am satisfied with the explanations I have been given. I agree that raw data from this 
research project can be held indefinitely for the purposes of future analysis and research.  I 
understand that taking part in this project is voluntary (my choice) and that I may withdraw 
from the project if necessary. 
 
I understand that I can withdraw from the project at any time up until a fortnight following the 
termination of the trial, for any reason. 
 
I understand that my participation in this project is confidential and that no material from which 
I might be identified will be used in any reports on this project. 
 
I have had enough time to consider whether I want to take part. 
 
I know whom to contact if I have any questions or concerns about the project 
 
The principal researcher and first contact for this project is: 
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Jesse Mason 
Master of Osteopathy student 
4 Wolseley Street, Morningside, Auckland 
(09) 846 5453 
(021) 771715 
mrjessemason@gmail.com  
 
 
Signature……………………………………………………….participant   ……….(date) 
 
Project explained by………………………………………….. 
 
Signature……………………………………………………….                   ………..(date) 
 
This study has been approved by the Unitec Research Ethics Committee from (date) to (date).  If you have any complaints or 
reservations about the ethical conduct of this research, you may contact the Committee through the Secretary (ph: 09 815-4321 ext 
8041).  Any issues you raise will be treated in confidence and investigated fully, and you will be informed of the outcome. 
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Appendix 3: Quadruple Visual Analogue Scale (QVAS) 
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Appendix 4: Neck Disability Index (NDI) 
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Appendix 5: Patient Specific Functional Scale (PSFS) 
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Appendix 6: Tampa Scale for Kinesiophobia (TSK) 
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Appendix 7: Fear Avoidance Beliefs Questionnaire (FABQ) 
 
 
 134 
Appendix 8: Subject 1 Bodychart 
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Appendix 10: Subject 3 Bodychart 
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Appendix 12: Subject 5 Bodychart 
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Appendix 13: Unitec Research Ethics Committee (UREC) Approval 
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Appendix 14: Unitec Research Ethics Committee (UREC) 
Amendment Approval 
 
 
